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Y-microsphere therapy has been widely accepted as a treatment option for both

primary and metastatic liver tumors where the patients are ineligible for surgical resection
and external beam radiation therapy. The prognosis of untreated patient having liver cancer
is very poor with life expectancy less than a year at advance stage. Hence the ability to
predict treatment efficacy right after the treatment from post-therapy imaging will help
personalize treatment strategies and achieve better outcome. Such prediction can be modeled
from correlation of dose and tumor response metrics.
It has been shown that local dose deposition method can generate dose map from
90

Y emission images with accuracy comparable to dose-point kernel and Monte Carlo

simulation methods. The bias and variability of the input images remain to be the weakest
link in volumetric dosimetry. The objectives of this dissertation project were to improve
image-based volumetric 90Y dose quantification using current commercially available
systems and to determine its limitation (bias/variability).
We have developed a practical image reconstruction method for 90Y bremsstrahlung
SPECT/CT (bSPECT/CT) images with CT attenuation correction and energy-window based
background compensation. Although the volumetric quantitative accuracy of our
bSPECT/CT images is limited by partial volume effect, the images can be used to accurately
vi

quantify the total 90Y activity delivered to the patient, which allow gross treatment delivery
verification and limited outcome prediction.
We have also characterized the accuracy and variability of volumetric 90Y
dosimetry calculated from count-limited 90Y-PET/CT images. Knowledge of overall errors
(systematic and random) in volumetric 90Y dosimetry is important to derive statistically
significant dose-response model, which in turn allowing prediction of treatment outcome and
personalization of treatment strategy.
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Chapter 1: Introduction

1.1.

Background
Liver cancer is the second leading cause of cancer-related death; accountable for

745,000 deaths in 2012 (9.1% total). The prognosis for liver cancer is very poor with the
mortality/incidence ratio of 0.95 (1). In the United States, the liver-cancer incidence and
mortality of 39,230 and 27,170 are estimated in the year of 2016 (2). Similar to the worldwide prognosis, the prognosis of liver cancer in the US is also very poor with the 1- and 5year survival rates of 44% and 17%. About 75% of the liver cancer cases are hepatocellular
carcinoma (HCC) cases. Liver is also a common site for metastatis from tumors in organs
that supply blood to portal vein, e.g., colorectal and pancreatic tumors.
Although surgical resection offers the best prognosis for liver-cancer patient, only <
25% of the patients are eligible for the procedure (3–6). These patients are usually not
eligible for external beam radiation therapy because of radiosensitivity of both tumor and
normal tissue. Radioembolization using radionuclide-doped microsphere is devised to
exploit the difference in perfusion between normal liver and liver tumors (both HCC and
metastatic) (7). In normal liver tissue, 70%–80% of the blood is supplied by the portal vein
and the rest is supplied by the hepatic artery. In contrast, 80%–100% of the blood supply to
liver tumor comes from the hepatic artery (8). This unique perfusion of the tumor allows
selective delivery of radionuclide-doped microspheres, using intra-arterial technique, to the
tumor while sparing the normal liver tissue. Note that the distribution of the microspheres is
mechanistic instead of biochemical distribution; hence the treatment technique is called
selective internal radiation therapy (SIRT) instead of targeted radionuclide therapy (TRT).
1

Currently there are two commercially available microspheres products: glass
microspheres (TheraSphere™; BTG Biocompatibles Ltd, Farnham, UK) and resin
microspheres (SIR-Spheres™; Sirtex Medical, Sydney, Australia). Resin microspheres are
FDA approved to treat colorectal cancer liver metastates, while glass microspheres are under
a humanitarian device exemption from the FDA to treat HCC. The differences in efficacy
and toxicity of these two sphere types are subject to ongoing debate (9, 10), although recent
studies show that the overall patient survival treated using either spheres is very comparable
(11).
Both resin and glass microspheres are doped with Yttrium-90 (90Y).
to deliver the radiation therapy because of its attractive therapeutic properties.

90

Y is selected

90

Y is

effectively a pure β- emitter with maximum and average β- energy of 2.28 and 0.934 MeV,
with half-life of 64.2 hours. This energy spectrum corresponds to maximum and average
penetration range of < 11 mm and < 4 mm in tissue, respectively. Hence, the 90Y
microspheres deposit their energy locally at their “target” location, which allows normal
tissue sparing during the radiation treatment.
Treatment planning for 90Y microspheres is done using surrogate 99mTc-MAA
(macro aggregated albumin). Many studies have shown that distribution of MAA is not a
consistent and reliable predictor of microsphere distribution (12, 13); therefore a direct
imaging of post 90Y-microsphere therapy is needed to confirm the delivery of 90Ymicrosphere distribution (qualitative imaging) and to predict the treatment outcome
(quantitative imaging).
Although it is desirable from safety point of views (normal tissue sparing and
patient release), as a pure β- emitter, 90Y presents a very unique challenge for direct 90Y
2

imaging.

90

Y planar and SPECT images can be acquired by imaging the bremsstrahlung

photons, produced as the β- particles interact with matter (liver parenchymal).

90

Y

bremsstrahlung imaging is very challenging (Chapter 2) mainly due to the absence of
photopeaks (γ and/or fluorescence x-ray) and sub-optimal hardware. Alternatively, 90Y
decay process also yield very low branch of 32 ppm positron emission, produced via internal
pair production. The annihilation photons can be imaged using PET imaging, which poses
very unique challenges as well due to very low signal (Chapter 3–5).

1.2.

Purpose statement
The long term goal of this project is to assess the efficacy (tumor response and

normal tissue toxicity) of 90Y-microsphere therapy by correlating image-based volumetric
dose quantification to tumor response and normal tissue complications, thus leading to
treatment-strategy personalization and better patient outcome. The objectives of this
dissertation project were to improve image-based volumetric 90Y dose quantification using
current commercially available systems and to determine its limitation (bias/variability).
A period of 4–8 months is required to reveal whether or nor not the tumor is
responding to 90Y-microsphere treatment (14). In normal clinical workflow, the follow-up
imaging procedure (e.g. CT, MR, 18F PET/CT, 99mTc-MAA SPECT/CT) to evaluate
treatment response is scheduled about 3 months after 90Y-microsphere therapy, the earliest;
while patients with advance liver cancer disease (both HCC and metastases), if left untreated,
usually survive for less than 6–12 months (15–18). Hence the ability to predict the efficacy

3

of treatment from post-therapy 90Y imaging will allow personalization of treatment strategy,
which will result in better outcome for the patient.
To realize this precision-medicine approach, several groups have used image-based
volumetric dosimetry (19–23) to derive the dose-response model for 90Y-microsphere
therapy.

90

Y dose maps have been calculated from either 99mTc-MAA SPECT/CT, 90Y

bSPECT/CT, or 90Y PET/CT images. At the current state of commercially available
technology, there seems to be a general agreement that 90Y PET/CT images are the better
estimation of 90Y activity (or dose) distribution. Studies have shown that 99mTc-MAA
(macro aggregated albumin) is not a consistent and reliable surrogate of 90Y-microsphere
distribution (12, 13); while

90

Y bSPECT/CT images have been shown to be inferior in image

resolution, image contrast, and hence volumetric quantitative accuracy compared to 90Y
PET/CT (24–26).
Nevertheless, in the United States, majority of post-treatment 90Y imaging
procedures, which are important to verify the treatment delivery, are done on SPECT/CT
scanners. Most recent development in bremsstrahlung SPECT/CT (bSPECT/CT) image
reconstruction has shown that with incorporation of physics modeling using Monte Carlo
simulation, it is possible to generate accurate quantitative bSPECT/CT images (27, 28).
However, these advance techniques are not widely available for clinics where 90Ymicrosphere therapies are done. In the specific aim 1 of this dissertation project, we have
developed a practical method, using commercially available SPECT/CT systems, to
reconstruct bSPECT/CT images with improved image quality and improved activity
quantification.

4

Recent 90Y-PET-based dose-response studies have not been able to show a
consistent and statistically significant relationship between dose metrics (D70 and/or Dmean)
and tumor response to 90Y-microsphere therapy (22, 23). Volumetric dosimetry that
incorporates radiobiological modeling is suggested to have improved dose-response model
(29–31). In addition, dose-response model also needs stratification based on microsphere
type, tumor type, dosimetry and response quantification methods (30, 32). Incorporation of
radiobiological modeling requires information of 3D dose distribution, which can be
estimated from 90Y PET/CT images (33–35). The performance of volumetric 90Y dosimetry
calculated from degraded 90Y PET/CT images, however, has not been characterized. In
specific aim 2–4, we characterized and optimized the performance of PET-based volumetric
dosimetry.

1.3.

Hypothesis and aims

1.3.1.

Central hypothesis
The central hypothesis of this dissertation is that optimization of 90Y emission

image reconstruction, using current commercially available imaging systems, can maintain
the overall errors (systematic and random) in volumetric dose quantification to < 20% in
clinically relevant imaging conditions.

1.3.2.

Specific aim 1

SA 1: Develop practical 90Y bremsstrahlung SPECT/CT imaging protocol.
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Several groups (27, 28) have shown that Monte-Carlo simulation can accurately
model the object attenuation, scatters, and collimator-detector response to reconstruct
quantitative bresmsstrahlung SPECT/CT (bSPECT/CT) images with quantification error of
mean activity concentration < 10%. These advance image reconstruction method, however,
are not commercially available and cannot be readily implemented in clinical practice,
especially in clinics that are not associated with academic hospital, a common practice in the
United States.
The objective of this aim is to improve image quality and 90Y dosimetry
quantification of bSPECT/CT images using a commercially available imaging system. We
tested the working hypothesis that energy-window based “background” compensation can be
used to improve volumetric dose quantification and image quality in 90Y bSPECT/CT.
In this aim, we developed a practical and simple methodology to determine
bremsstrahlung imaging energy window (EW) and to correct for attenuation (CT-based) and
“background” signal (EW-based). This methodology can readily be applied in clinical
practice to improve image quality and quantification of 90Y bSPECT/CT images.
Research design:
•

SA 1.1: Determine the imaging EW for 90Y bremsstrahlung imaging

•

SA 1.2: Develop the EW-based background compensation model

•

SA 1.3: Optimize the image reconstruction parameters

•

SA 1.4: Establish the count-to-activity calibration factor

1.3.3.

Specific aim 2

SA 2: Optimize 90Y PET/CT image reconstruction for volumetric dose quantification.
6

Volumetric dosimetry has been calculated from 90Y PET images (20, 22, 25). Recent
studies on image reconstruction-parameters optimization for quantitative 90Y PET imaging
(24, 36–39), however, have still been based on mean-activity-concentration recovery
coefficient as the objective function, which is more relevant to diagnostic dosimetry and
detection tasks.
The objective of this specific aim was to improve quantification of volumetric 90Y
dosimetry by optimizing the image-reconstruction protocol. Our working hypothesis for this
aim was that using dose volume histogram estimate (DVH’), instead of mean dose recovery
coefficient, as the optimization objective function would result in smaller errors in 3D dose
distribution.
Traditional objective function of mean dose recovery coefficient can only be used to
optimize the number of equivalent iterations and it does not take into account the change of
3D dose distribution due to image noise. In this aim, using errors of DVH’ as the objective
function, we were able to concurrently optimized the number of equivalent iterations and the
filtration full width at half maximum and, consequently, minimized the errors in volumetric
quantification of 90Y dose distribution.
Research design:
•

SA 2.1: Optimize the number of equivalent iterations (subset × iteration) based on
convergence of mean dose recovery coefficient (RC).

•

SA 2.2: Optimize the reconstruction parameters (equivalent iterations and filter FWHM)
based on the errors in DVH’.
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1.3.4.

Specific aim 3

SA 3: Determine the errors and variability of volumetric dose quantification from 90Y
PET/CT images
Volumetric 90Y dose has been quantified (22, 23, 25) using cumulative dose volume
histogram calculated from 90Y PET images (DVH’) and has been used to empirically derive doseresponse relationship to predict treatment outcome.

90

Y PET images, however, are subject to image

degrading factors such as partial volume effect, image noise, and motion blur (40). Consequently, the
DVHs’suffer from errors due to these degrading factors. While these factors degrade all emission
imaging, 90Y PET imaging presents a unique challenge in the extremely low signal (positron yield of
32 ppm).
Despite increased use of 90Y PET images for volumetric 90Y dosimetry, the impact of very
low signal on the errors, both systematic and random, in the resulting DVH’ and it summary metric
(e.g., Dmean and D70) has not been thoroughly evaluated.

The objective of this aim was to characterize the systematic and random errors in
quantification of 90Y volumetric dose distribution from 90Y PET images. The working
hypothesis of this aim was that partial volume effect governs the errors in volumetric dose
quantification; while the count limitation determines the random errors.
In this aim, we characterized the overall errors (systematic and random) of volumetric
quantification of 90Y dose distribution from 90Y PET/CT images, which are important in
designing clinical studies to derive the dose-response correlation derived using dose metrics
from 90Y PET images. Knowledge of the limitation in the dose metrics also allow
understanding of the confidence level of the response prediction.
Research design:
•

SA 3.1: Characterize the effects of the activity-dependent bias
8

•

SA 3.2: Determine the impact of image noise (duration) and partial volume effect (PVE)
on image-based volumetric dose quantification

1.3.5.

Specific aim 4

SA 4 : Determine the effectiveness of quiescent period gating (QPG) method for reducing
errors in volumetric dose quantification from 90Y PET/CT images.
90

Y-PET acquisition duration can be up to 30 min/bed, during which, the PET data

acquired are degraded by motion blur due to time-averaging of multiple breathing cycles
(typically 4 s/cycle). Although motion correction has been subject to active research in 18FPET/CT imaging (41–44), effect of motion blur on volumetric 90Y dose distribution and
motion compensation strategies in 90Y PET/CT imaging have not been evaluated.
Most widely used motion correction technique is gating-based PET/CT acquisition
at quiescent respiratory period (45). Quiescent period gating (QPG) method–both phased
and amplitude-based methods–group the acquired data into smaller bins to minimize the
spatiotemporal mismatch in the data due to the respiratory cycles (46). Each bin will have
reduced systematic errors due motion blur, but each data will have lower counts. As a result,
gating-based technique trades off systematic errors due to motion blur with both systematic
and random errors due to lower signal used to reconstruct the gated PET images. In contrast
to 18FDG PET/CT imaging, where the acquisition duration is usually 3 min/bed, in 90YPET/CT imaging with duration of 30 min/bed, it is practically not possible to increase the
duration to compensate for the count loss.
The objective of this aim was to determine if motion compensation using QPG is
effective at reducing the overall errors in quantification of volumetric 90Y dose distribution
9

using dose volume histogram calculated from 90Y PET images. Our working hypothesis was
that tumor with relative motion range < 1 does not benefit from QPG motion compensation
because the overall errors in the DVH’ calculated from the compensated 90Y images are not
reduced by the motion compensation.
In this aim, we characterized the impact of both low count, and motion blur, and the
effectiveness of their trade-off using QPG on quantification of volumetric 90Y dose
distribution (DVH’). We found that QPG motion compensation did not always reduce the
overall errors in DVH’; therefore this work is important because it allows identification of
90

Y PET/CT imaging condition where the volumetric tumor dosimetry can benefit from QPG

motion compensation.
Research design
•

SA 4.1: Evaluate the impact of increase image noise (due to gating) on AC
quantification

•

SA 4.2: Evaluate the impact of motion on activity distribution quantification

•

SA 4.3: Determine the effectiveness of QPG method in improving AC quantification
in 90Y PET/CT images suffering from motion blur

1.4.

Significance and Innovation

1.4.1.

Significance
In the specific aim 1 of this dissertation project, we have developed a practical

method, using commercially available SPECT/CT systems, to reconstruct bSPECT/CT
images with improved image quality and improved activity quantification. Although the
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quantitative accuracy of our bSPECT/CT images is very limited by partial volume effect (due
to sub-optimal collimator design), the background compensated and attenuation corrected
bSPECT images can be used to accurately quantify the total 90Y activity delivered to the
patient, which allow gross treatment delivery verification and limited outcome prediction.
Recent 90Y-PET-based dose-response studies (22, 23) have not been able to show a
consistent and statistically significant relationship between dose metrics (D70 and/or Dmean)
and tumor response, partly because the accuracy and variability in the dose metrics are
largely unknown. In specific aim 2–4, we characterized the accuracy and variability of
volumetric 90Y dosimetry calculated from count-limited 90Y-PET/CT images. Knowledge of
overall errors (systematic and random) in volumetric 90Y dosimetry is significant because it
is the first step in a continuum of research that is expected to derive statistically significant
dose-response model, which in turn allowing prediction of treatment outcome and
personalization of treatment strategy.
In addition, it has been suggested that the dose-response model can be improved by
incorporating radiobiological models, which require information of 3D dose distribution. 3D
90

Y dose maps calculated from 90Y-PET/CT images are subject to image degrading factors

that affect the 90Y-PET/CT images. In addition to characterizing the overall errors, in
specific aim 2–4, we also improved the estimated 90Y dose map by optimizing the image
reconstruction protocol and compensating motion blur.

1.4.2.

Innovation
The innovation of bSPECT/CT imaging in specific aim 1 is that we developed an

empirical background compensation based on adaptation of energy-window based scatter
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estimation. The proposed reconstruction method is very practical that it does not need any
advance techniques such as Monte-Carlo simulation based reconstruction, which is not
widely available for clinical use.
Methods to generate dose map from 90Y PET/CT images have been developed (33–
35). The volumetric 90Ydose distribution inside the tumor margin, which is calculated from
the dose map estimate, has been used to derive dose-response model and to predict treatment
outcome (21–23, 47). The quantitative reconstructions of these 90Y PET/CT images,
however, are optimized for quantifying mean dose (24, 36–39), instead of quantifying the 90Y
dose distribution used to generate the 90Y dose map estimate. The innovation in specific aim
2–4 on 90Y-PET/CT imaging is that we characterized the quantification errors (systematic
and random) of volumetric 90Y dose distribution calculated from 90Y PET images. The
volumetric 90Y dose distribution was quantified using dose volume histogram estimate
(DVH’). In specific aim 2, we optimized 90Y PET/CT image reconstruction by minimizing
the errors in DVH’, which was innovative because, to the best of our knowledge, there have
not been any published works on optimizing 90Y PET/CT image reconstruction other than
using recovery coefficient of mean activity concentration as the objective function. In
specific aim 3 and 4, we quantified the errors (systematic and random) in DVH’ due to count
limitation and motion blur, respectively.

1.5.

Chapters organization
The main body of this dissertation consists of 3 chapters, each written in manuscript

form for peer-review journal publication. Chapter 2 addresses specific aim 1. Chapter 3
addresses specific aim 2 and 3. Chapter 4 addresses specific aim 4. The final chapter 5
12

consists of summary about the key findings in this dissertation work, study limitation and
future work.
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Chapter 2: Practical reconstruction protocol for quantitative 90Y bremsstrahlung
SPECT/CT
2.1.

Introduction
Yttrium-90 microsphere therapies are used in the management of unresectable

primary and metastatic liver cancers.(48, 49) In treatment planning, the radiopharmaceutical
macro-aggregated albumin (99mTc-MAA) is used as a surrogate for 90Y microspheres. First,
planar imaging is used to determine the lung shunt fraction, which is incorporated into the
dosimetry calculation to prevent radiation pneumonitis from 90Y therapy. Next, singlephoton emission computed tomography (SPECT)/computed tomography (CT) imaging is
used to determine whether there is extrahepatic uptake of the 99mTc-MAA and adequate
perfusion of the target lesions. However, several studies have shown that the distribution of
99m

Tc-MAA prior to treatment may not be a consistent and reliable indicator of the post-

treatment distribution of the 90Y-microspheres.(12, 13) These potential discrepancies in
distribution between planning 99mTc-MAA and treatment 90Y-microspheres support the need
for post-treatment 90Y imaging to assess treatment delivery. However, bremsstrahlung 90Y
imaging is challenging.
In contrast with the majority of the radionuclides used in nuclear medicine imaging,
90

Y is effectively a pure beta emitter, i.e., it lacks discrete-energy photon emissions, such as

gamma rays and/or characteristic fluorescence X-rays. The X-ray photons emitted by 90Y are
very low in both yield (<< 1 ppm) and energy (<< 18 keV), and the gamma photons emitted
by 90Y have an insignificant yield (<< 1 ppm) and very high energy (~ 2 𝑀𝑒𝑉). Yttrium-90

activity distribution in vivo is traditionally assessed by imaging the bremsstrahlung photon,
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which is produced from interactions of energetic beta particles with soft tissue, using planar
and/or SPECT/CT imaging.
Yttrium-90’s lack of photopeaks has stunted standardization of 90Y bremsstrahlung
imaging procedures; consequently, image quality varies widely amongst different facilities.
The 90Y decay process also has a very small branching to the excited state of stable 90Zr,
which is followed by an internal pair production (32 ppm per β- decay).(50) The positrons
generate a pair of 511-keV annihilation photons that can be imaged using 90Y positron
emission tomography (PET)/CT. Recent studies have suggested that 90Y PET/CT imaging
provides better image quality (contrast and resolution) and quantification than
bremsstrahlung SPECT/CT.(24, 25) Preliminary results of studies of tumor dosimetry,
treatment response, and toxicity based on quantitative 90Y PET/CT and 90Y SPECT/CT posttherapy imaging have been presented. (14, 22, 51) However, at present, there is no wellestablished standardized imaging protocol for 90Y imaging in vivo with either SPECT/CT or
PET/CT.
In contrast to gamma and X-ray emitter imaging, in which the object spatial information is
carried by photons with a discrete energy, bremsstrahlung imaging’s the object spatial
information is carried by photons with a continuous energy distribution. In discrete energy
photopeak imaging, the imaging energy window (EW) is defined such that it accepts most of
the primary photon emission while rejecting most of the scatter. The EW is usually centered
on the photopeak and its extend (width) is governed by the energy resolution of the gamma
camera, however the continuous nature of 90Y photon emissions prohibit such
straightforward approach. Simulation work (52, 53) have shown that a typical 90Y
bremsstrahlung emission spectrum from 90Y activity in the liver can be expressed as the sum
15

of 5 spectral components: primary bremsstrahlung, object scatter, camera backscatter,
collimator scatter and penetration, and lead X-rays produced in the collimator. At any given
EW, the ratio of primary bremsstrahlung to the total number of photons detected is < 15%,
with the highest primary fraction around 80–180 keV.(52–54)

Research on improving 90Y bremsstrahlung imaging both qualitatively and
quantitatively is ongoing, but most of the published solutions require some sort of Monte
Carlo simulation. Rong et al used Monte Carlo simulations to accurately model the energy
dependent object attenuation, scatter and the collimator-detector response to obtain
quantitatively accurate images(27). The net percent errors in activity estimates from physical
geometrical phantom experiments and simulated patient data were shown to be 5-10 %.
Elschot et al directly incorporated into the reconstruction algorithm the energy dependent
photon scatter and attenuation estimated from Monte Carlo simulations(28). Their approach
demonstrated higher tumor contrast and lower mean residual count in lung insert albeit at the
cost of higher image noise. These advanced Monte Carlo based approached are not
commercially available and cannot be easily implemented in the routine clinical practice. The
lack of their widespread use is further exacerbated by the fact that many 90Y procedures, at
least in the United States, are performed in interventional radiology clinics that are often not
associated with academic hospitals.
The objective of this study was to develop a practical imaging protocol to improve
90

Y bremsstrahlung SPECT/CT image quality and quantification that could be readily

implemented on commercially available imaging systems. To accomplish our objective, we
developed a simple method for determining an appropriate imaging EW, its EW-based
background compensation (BC), and CT-based attenuation correction (AC). Furthermore, we
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present approaches for the optimization of SPECT reconstruction parameters for both
detection and quantification. Finally, we address the implementation and accuracy of selfcalibration that lead to total activity quantification from 90Y SPECT/CT images.

2.2.

Methods
All data acquisition and analysis were performed on Symbia TruePoint SPECT/CT

systems (Siemens Medical Solutions, Hoffman Estates, IL, USA).
2.2.1. Defining energy windows for CT attenuation correction
Six preliminary EWs (the maximum allowed on the SymbiaTruePoint SPECT/CT
systems) were defined in order to separate the total 90Y bremsstrahlung spectrum into regions
dominated by different spectral components: 70–100 keV (object scatter and lead X-rays),
100–125 keV (object scatter), 125–175 keV (backscatter), 175–225 keV (backscatter), 225–
300 keV (backscatter, collimator scatter and septal penetration), and 300–400 keV
(collimator scatter and septal penetration). The maximum widths of the EWs were
constrained by the ability to accurately represent photon attenuation at the mean energy of
each window to facilitate SPECT AC, such that, if Δµ is the difference in linear attenuation,
µ, between the extreme energies of a window, we required Δµ/µmean < 10%. The 10% limit
on Δµ was based on earlier work that showed that SPECT images were accurate to within 1%
when Δµ/µmean< 6%.(55)
The electron density phantom we used (model 062, CIRS, Norfolk, VA) enables
precise correlation of CT data in Hounsfield units (HU) to the linear attenuation coefficient,
µ (cm-1). It includes 8 different reference tissues with CT values ranging from −790 HU
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(lung inhale) to 235 HU (trabecular bone). An axial CT scan of the electron density phantom
was performed at a high tube current to minimize CT noise (130 kVp, 200 mAs). The CT
image was converted into µ-maps using proprietary software (e.Soft, Siemens Medical
Solutions) that converted each CT image into a μ-map at a user-defined emission energy at 5
keV intervals from 70–511 keV (the range is limited by the software). Circular regions of
interest (ROIs) were drawn within the inserts to calculate their µ as a function of photon
energy.
Starting with the above-defined 6 EWs, we iterated on the EW widths so that the
Δµ/µmean was < 10% in each EW for the adipose, soft tissue, muscle, and liver inserts.
Considerations were also made to isolate the various scatter components in different EWs.

2.2.2.

Choosing appropriate imaging energy windows
In this work, the primary signal was assumed to be spatially registered within the

object, while the background signal was considered to be more widely distributed across the
image. It is important to note that this primary signal definition may contain object scatter in
addition to the primary bremsstrahlung and perhaps even some smaller contributions from
collimator scatter, septal penetration, and backscatter. We defined the imaging EW as the
EW that had the highest fraction of primary signal to background signal.
Fig 1 shows the phantom experiment setup, which acquired using a gamma camera
with 1.6-cm (5/8-inch) crystal. Yttrium-90 (III) chloride solution was placed in a vial (8.5
cm × 3.3 cm) 1 cm. The 90Y phantom was positioned at 30 cm above the gamma camera
with a medium-energy low-penetration (MELP) collimator. Acrylic slabs of various
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thicknesses (2, 5, 9, 12, and 16 cm) were placed right below the phantom to introduce
attenuation and scatter. For the 5 cm-thick acrylic slab, the distance between the collimator
and the phantom was varied to 15, 20, 25, 30, and 35 cm. Planar static images were acquired
for each imaging condition. Each static image was acquired in the 6 EWs determined in Sec.
2.A. For each imaging condition, planar images with 2 million counts were acquired in the
90–125 keV EW.

Fig 1. The experimental setup used to acquire 90Y planar images under different imaging
conditions. Both the acrylic thickness and the distance between the collimator and the
phantom were varied.
To calculate the signal-to-background ratio, we drew 2 ROIs on each of the static
images (Fig 2): a small ROI at the center, enclosing the image of the object, and a larger
ROI that enclosed the entire field of view (FOV). The total counts in the small ROI
represented the numbers of photons carrying more object spatial information. This was
designated as the primary signal. The total counts in the periphery, calculated by subtracting
the total counts in the smaller ROI from those in the larger ROI, represented the number of
scattered photons that had already lost their spatial information. This was designated as the
background signal.
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For each EW, the mean pixel count per keV was calculated by dividing the total
counts from the ROIs by the EW width and the number of pixels in the ROI. Signal-tobackground ratio was calculated as the mean pixel count/keV in the center divided by the
mean pixel counts/keV in the periphery. The signal-to-background ratios were calculated for
all static phantom images (all 6 EWs for all imaging conditions). The EW with the highest
signal-to-background ratio was used as the imaging EW.

Fig 2. The larger ROI (periphery), indicated in red, encloses the entire FOV of the
gamma camera. The smaller ROI (center), indicated in blue, encloses the projected
image of the phantom. The background counts in the periphery region were calculated
by subtracting the counts for the small ROI from those of the large ROI. The small ROI
contains both the primary signal counts, which carry more object spatial information, and
unwanted background counts.

2.2.3.

Developing empirical energy window-based background compensation for 90Y

bremsstrahlung imaging
Our empirical EW-based BC model adapted the EW-based scatter correction model,
in which the scatter in the imaging EW is estimated as a scaled image of the scatter-estimate
EW.(56–58) In this work, we used scaled images of the BC EW as a model to compensate
for the background signal in the imaging EW. The BC EW was selected empirically from
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our phantom study and based on the errors in the activity recovery coefficient and the amount
of residual background count in the cold lung insert. The scaling coefficients were calculated
from clinical images. The use of a single scaling coefficient for BC can be justified if low
variation in the scaling coefficients is observed under clinical imaging conditions. We used
clinical planar images (anterior and posterior views) of 10 post-90Y-microsphere therapy
patients with inherent random geometries (patient thicknesses and distance to collimator).
The images were acquired using a Symbia T gamma camera with a crystal thickness of
1.6 cm. For each potential BC EW (5 EWs: A, C, D, E, and F), the scaling coefficients were
derived by averaging the scaling coefficients calculated for each clinical planar image of the
10 patient scans, for 20 images in total. The scaling coefficients were calculated as the ratio
of the periphery ROI total counts in the imaging to the potential BC EWs (Fig 3). The
variations in the scaling coefficients for each potential BC EW in the clinical scans were
reported as 1 standard deviation.

Fig 3. Clinical planar images in imaging (A) and potential background compensation (B)
energy windows showing the positioning of regions of interest (outside but adjacent to
the liver) from which the total counts were extracted to calculate the scaling coefficient
for the empirical background compensation model. The area superior to the liver was
excluded to avoid including any signal contamination from the lung shunt.
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The most appropriate BC EW was determined empirically according to 2 criteria: 1)
the maximum recovery coefficient of the 37-mm sphere and 2) the minimum residual activity
concentration in the cold lung insert of a NEMA IEC body phantom (Biodex, Shirley, NY).
The phantom was filled with 2.8 GBq (75.4 mCi) 90YCl3 with the sphere-to-background ratio
of 7.8. SPECT/CT images of the phantom were acquired for 28 s/view for 2 × 64 views over
360° using Symbia T6 SPECT/CT systems with 1.6 cm NaI(Tl) detectors and MELP
collimators. The acquisition EWs were chosen based on the results reported in Sec. 3.B.
SPECT/CT images of the IEC phantom were reconstructed using the Ordered
Subset Expectation Maximization (OSEM) (Flash 3D, Siemens Medical Solutions) algorithm
with CT attenuation (See Sec. 2.A) and 5 different BC models. The number of equivalent
iterations (subset × iteration) was 8 × 8 (based on results reported in Sec. 3.E). The
reconstructed images had a matrix size of 128 × 128 and a voxel size of 4.8 mm. No postreconstruction filter was applied to the images to avoid further image resolution degradation
on inherently poor-resolution bremsstrahlung 90Y images.
For each reconstructed image set, a spherical volume of interest (VOI) with a
diameter of 10 mm was placed inside the 37-mm sphere, and cylindrical VOIs with diameters
and lengths of 25 mm were placed in the adjacent background and in the lung insert. A VOI
of 10 mm in diameter for the 37-mm sphere was chosen to decrease the partial volume effect.
Observed sphere-to-background ratio recovery was calculated from the mean counts inside
these VOIs, i.e., meansphere/meanbackground. Residual activity concentration in the lung insert
was calculated as a fraction of mean count in the background, i.e., meaninsert /meanbackground.
The most suitable BC model was determined based on the recovery of the true sphere-tobackground ratio (measured/true) and the residual mean count in the lung insert.
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The improvement in image contrast after BC was evaluated visually and semiquantitatively by comparing the contrast-to-noise ratio (CNR) of the lesions before and after
the BC was applied. The CNRs of the lesions were calculated as
CNR =

meanlesion −meanbackground
�meanbackground

; where meanlesion and meanbackground are mean ROI counts in

the hot lesions and warm liver, respectively.

2.2.4.

SPECT/CT activity calibration for quantification
The SPECT calibration factor was defined as the ratio of the total activity in the

FOV to the total counts in the FOV. For ideal image reconstruction (with accurate
corrections for scatter, attenuation, and collimator-detector response), calibration with a point
source in air suffices. In practice, however, the image reconstruction is not ideal, so the
calibration factor is usually derived from phantom images with all the necessary corrections
applied. It is imperative that the calibration of the SPECT/CT imaging system remain valid
under clinically relevant conditions to minimize the variations in activity quantification that
may result from a mismatch between the calibration and clinical imaging conditions.
Post-therapy 90Y SPECT/CT scanning presents a unique condition in which the total
90

Y activity inside the liver (and hence inside the SPECT FOV) can be determined with

uncertainty < 10%. Clinical images acquired under such conditions can be used to calibrate

the SPECT/CT imaging system. In this study, the calibration factors were calculated from 30
post-90Y-microsphere therapy SPECT/CT studies with a wide range of abdomen sizes, from
19–40 cm (measured in the anterior-posterior direction from the transaxial CT images). The
patient scans were chosen such that the net administered activity could be determined with
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high accuracy. Activity uncertainty in the FOV was maintained at < 7% by selecting patient
scans with a lung shunt fraction < 5% and administered activity residuals ≤ 2% and by
assuming the error in dose calibrator assay ≤ 3%.

All clinical images were acquired using gamma cameras with a crystal thickness of

1.6 cm in the EWs described in Secs. 2.A and 2.B. The planar images were acquired for
10 min with a matrix size of 256 × 256 and pixel size of 2.4 mm. The SPECT projection
images were acquired for 28 s/view for 2 × 64 views over 360°. The SPECT images were
reconstructed using the OSEM algorithm with number of equivalent iterations of 64,
(optimized in Sec. 2.E), matrix size of 128 × 128, voxel size of 4.8 mm, and postreconstruction Gaussian filter of 4.8 mm.
The calibration factors were calculated for the following image types: planar
images, SPECT images with no correction (SPECT only), SPECT images with CT-based AC
(Sec. 2.A) (SPECT with AC), and SPECT images with both CT-AC (Sec. 2.A) and BC (Sec.
2.C) (SPECT with AC+BC). For each image type, we used linear regression analysis to
derive the relationship between the total injected activity in the FOV and the corresponding
total count rates (total counts/frame duration) in the same image FOV. The global calibration
factor and its uncertainty were calculated from the regression equation as the gradient and its
standard error. The validity of using a single global calibration factor under various clinical
imaging conditions was evaluated based on the standard deviation of the residuals (the
difference between the actual activities with the predicted injected activities with respect to
the actual values) in the linear regression analysis.
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2.2.5.

Reconstruction-parameter optimization for qualitative and quantitative

SPECT/CT images
The IEC phantom data acquired in Sec. 2.C were also used for this section. The
SPECT/CT images were reconstructed using the 3D-OSEM (Flash 3D) algorithm with CT
attenuation (Sec. 2.A) and a final empirical BC model (Sec. 3.C). We varied the number of
equivalent iterations(59) from 8 to 256: 8 subsets with 1–16 iterations and 16 subsets with
12–16 iterations. The reconstructed images had a matrix size of 128 × 128 and a voxel size
of 4.8 mm. No post-reconstruction filter was applied to the images. For each total number of
iterations, the SPECT/CT count-to-activity calibration factor was calculated as the total
injected 90Y activity divided by the total counts in the entire reconstructed volume. Selfcalibration of the respective SPECT/CT images was performed for absolute image
quantification, i.e., voxel unit in Bq/mL.
Spatial resolution (partial volume effect) and convergence of iterative
reconstruction both affect the SPECT quantitative accuracy. For each reconstructed image, a
spherical VOI with a diameter of 10 mm was placed inside the 37-mm sphere, and cylindrical
VOIs with a diameter and length of 25 mm were placed in the adjacent background and in
the lung insert. VOI of 10 mm in diameter for 37-mm sphere was used to minimize the
partial volume effect. Measured sphere-to-background ratios were calculated from the mean
counts inside these VOIs (meansphere/meanbackground). The total number of iterations was
optimized based on the recovery of the true SBR, i.e., SBR measured /SBR true . The activity

quantification accuracy was measured as the activity recoveries in the 37-mm sphere and in
the background, i.e., measured activity/true activity. The efficacy of the EW BC was also
evaluated by measuring the relative activity in the lung insert with respect to the background
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activity. In addition, the activity quantifications in the 37-mm sphere and in the background
using SPECT with CT AC+BC were also compared with the activity quantification in
SPECT with AC.

2.3.

Results

2.3.1. Defining energy windows for CT attenuation correction
Table 1 shows the 6 energy windows (EW A–B) that maintained Δµ/µmean < 10%
for each of the 4 materials considered. The Elow and Ehigh limits were very similar for all 4
materials. The average Elow and Ehigh values are shown in the column of Table 1 labeled
“AverageCT-AC”. When considering BC, it is best to define the EWs such that the various
spectral components are isolated in different EWs (e.g., the dual-EW technique uses 1
window for photopeak + scatter and a second window for scatter only). Since individual
separation of 5 spectral components of bremsstrahlung is not possible because of its
continuous nature, we adjusted the AverageCT-AC windows to maximize separation between
the various spectral components. These EW definitions are labeled “NominalAC,SC” and were
selected as the acquisition EWs in this experiment. Based on the energy and spatial
distribute`on analyses, EW B (90–125 keV) was determined to be the primary imaging
window.
Adipose

Soft Tissue

Muscle

Liver

AverageCT-AC

NominalAC,BC

CT #

−63.6

−4.4

40.1

48.7

n/a

n/a

A

70–90

70–90

70–90

70–90

70–90

70–90
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B

90–130

90–125

90–125

90–125

90–126

90–125

C

130–175

125–180

125–170

125–170

126–174

125–160

D

175–235

180–245

170–230

170–230

174–235

160–215

E

235– 310

245–320

230–305

230–300

235–309

250–310

F

310–400

320–420

305–410

300–400

309–408

310–410

Table 1. The low and high photon energy limits of the 6 energy windows for < 10% change
in the attenuation coefficient (AverageCT-AC) for adipose, soft tissue, muscle, and liver, and
modified for energy window-based background compensation (NominalAC,BC). CT numbers
are in HU units and energy windows A–F are in keV.

2.3.2.

Choosing an appropriate imaging energy window
The calculated SBRs from the images acquired under different imaging conditions

(scattering material thickness of 2−16 cm at 30 cm away from the MELP collimator and
scattering material thickness of 4.8 cm at 15–35 cm away from the MELP collimator)
exhibited similar patterns, i.e., the sphere-to-background ratio was the highest in EW B
(~8.53), as shown in Fig 4.
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SBR
EW
A
B
C
D
E
F

mean
8.13
8.53
6.65
4.50
3.41
2.97

stdev
17%
17%
13%
9%
8%
12%

Fig 4. The signal-to-background ratios (SBR) of 6 energy windows (EWs) for the tested
attenuating material thicknesses and source-to-collimator distance combinations,
indicated by different bar colors. EWs A, B, and C had high signal-to-background ratios,
i.e., they contained relatively high spatial information, whereas EWs E and F had low
signal-to-background ratios, i.e., they contained relatively low spatial information. The
means and standard deviations (stdev) of the SBRs for the EWs are shown in the adjacent
table.

2.3.3. Developing empirical energy window-based background compensation for 90Y
bremsstrahlung imaging
The mean scaling coefficients ± 1 standard deviation for each BC model were 0.92
± 0.04, 0.91 ± 0.05, 0.55 ± 0.05, 0.75 ± 0.09, 0.53 ± 0.07 for EWs A, C, D, E, and F,
respectively. The coefficient of variance of the scaling coefficients was ~10%, which
suggests that a fixed scaling coefficient factor may be implemented for BC in clinical
images.
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Using EW F for BC in SPECT/CT image reconstruction of the IEC phantom
fulfilled both criteria: maximum SBR recovery and minimum lung insert residual activity;
therefore, the EW-based BC for imaging EW B can be modeled as EW B − 0.53 × EW F.

Using this model, the SBR recovery coefficient for the 37-mm sphere of the IEC phantom
was the highest at 87%, and the lung insert residual activity was the lowest at 14%, as shown
in Fig 5.

Fig 5. Recovery coefficients for 37-mm sphere and lung insert residual in the IEC phantom
for SPECT/CT images reconstructed without background compensation and with 5 models of
background compensation.
Fig 6 shows clinical examples of background-compensated planar images from 4
different patients. The BC improved the image contrast of the planar images. The tumors’
detectability as measured by CNRs (shown beside selected tumors in Fig 4 increased after the
application of the proposed BC. While the edges of the images still look fuzzy because of the
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inherently poor resolution of 90Y, whose maximum beta range is 11 mm in water, improved
delineation of the liver and liver lobes is apparent.

Fig 6. The uncorrected and background-compensated clinical images demonstrating that the
energy window-based background correction improves the visualization of the liver and
lesions. All images are shown using the same window width and level. The backgroundcorrected images show improvement in the contrast-to-noise ratios of the lesions (inset
numbers), which corresponds to improved visibility. The corrected images also exhibit
improved liver and tumor delineation.

2.3.4.

SPECT/CT activity calibration for quantification
For various reconstructed SPECT and planar images, the global calibration factors

(gradients), their uncertainties (standard errors of the gradients), and the coefficients of
determination (R2) of the regression lines are presented in Table 2. In all cases, the total
counts observed were proportional to the 90Y activity in the FOV with R2 > 0.9. As expected,
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the variations in the calibration factors exhibited the lowest variation in SPECT with AC +
SC and the highest in SPECT-only and planar images.
The activity residual in EW B after linear regression is plotted in Fig 7; the
standard deviations of the activity residuals were 11.3%, 5.6%, 5.2%, and 9.1% for SPECT
only, SPECT with AC, SPECT with AC + SC, and planar images, respectively. Activity
predictions using SPECT with AC and SPECT with AC + SC had lower variation than did
predictions made using SPECT-only or planar images. The predicted activity in an IEC
phantom using the global calibration factor derived from clinical scans introduced an error of
−25% with respect to the true injected activity.

Image Type

R2

CF (Bq/cps)

Std. Error (%)

SPECT

0.901

7.5

6.9%

SPECT AC

0.972

2.3

4.0%

SPECT AC + BC

0.982

4.0

2.8%

Planar

0.917

417.5

5.7%

Table 2. Results of the linear regression analysis of the relationship between total activity in
the field of view and the corresponding total counts in the images. AC: attenuation
correction, BC: background compensation, CF: calibration factor.
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Fig 7. The activity residuals, defined as the difference between the true and predicted values
relative to the true value, in EW B (90–125 keV) after linear regression. (A) Variations from
SPECT/CT images with attenuation correction and background compensation. The mean and
the maximum of the absolute deviation were 4% and 10%, respectively. The red square
indicates the data point from the IEC phantom with a sphere-to-background ratio of 8. (B)
Variations from SPECT/CT images with attenuation correction only. The mean and the
maximum of the absolute deviation were 4.5% and 12%. (C) Variations from uncorrected
SPECT images. The mean and the maximum of the absolute deviation were 9% and 27%,
respectively. (D) Variations from total counts in opposing planar views. The mean and the
maximum of the absolute deviation were 10% and 23%, respectively. SD: standard
deviation.

32

2.3.5.

Reconstruction-parameter optimization for qualitative and quantitative

SPECT/CT images
2.3.5.1. Quantitative SPECT/CT imaging
The activity concentration and SBR recovery of the 37-mm sphere and the activity
recovery in the background region in SPECT/CT images of the IEC phantom with CT AC +
BC are shown in Fig 8. The background activity concentration converged rapidly (after 16
iterations), while the 37-mm sphere activity converged more slowly (after 128 iterations).
The activity concentration in the background was fully recovered (~100%) at convergence
and the activity concentration in the 37-mm sphere was partially recovered (90%) at
convergence. The SBR recovery (87%) converged after 128 iterations as well. The
measured activity concentration in the cold lung insert was calculated with respect to the
background activity. The activity concentration in the cold lung insert vanished slowly as a
function of total number of iterations. At 128 iterations, the activity concentration in the lung
inserts was 14% of the activity concentration in the background.
As a comparison, at 128 iterations, the SPECT/CT images of the IEC phantom
reconstructed using CT AC only had recovery of 39%, 82%, 48%, and 44% for the sphere,
background, SBR, and lung insert, respectively.
The proposed BC method increased the activity concentration in the sphere and the
SBR recovery by more than 2-fold (from 39% to 90%). The false-positive activity in the
cold lung insert fell from 44% to 14%.
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Fig 8. Recovery coefficients as a function of the total number of iterations. The
background activity concentration reached 100% recovery rapidly (after 16 number of
equivalent iterations). The activity concentration in the 37-mm spheres (using a
10mm-diameter VOI to minimize the partial volume effect) reached a plateau after
128 equivalent iterations (90% recovery). After 128 equivalent iterations, the signalto-background ratio recovery also reached a plateau. The measured activity
concentration in the cold lung insert was calculated with respect to the background
activity. At 128 iterations, the activity concentration in the lung insert was 14% of
the activity concentration in the background. The error bars indicate standard
deviations for the volumes of interest. SUB: subset, IT: iteration.

2.3.5.2. Qualitative SPECT/CT images
As the number of equivalent iterations increased, the recovery of the activity in the
sphere also increased. For OSEM reconstruction, however, the background noise also
increased as a function of the number of equivalent iterations, as demonstrated by the
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growing error bars in Fig 8 as a function of the number of equivalent iterations. Fig 9 shows
the 37-mm sphere detectability (measured as CNR) as a function of the number of equivalent
iterations. The highest CNR, 25, was achieved at 16–24 number of equivalent iterations
before the sphere activity concentration converged. At convergence (64 iterations), the CNR
had decreased to 18 for SPECT with AC + SC and 13 for SPECT with AC. Visually, more
spheres were detectable at lower iterations [Fig 9 (a)] than at higher iterations at convergence
[Fig 9(b)]. SPECT with AC [Fig 9 (c)] had lower detectability than did SPECT with AC +
BC.

Fig 9. (left) Detectability (contrast-to-noise ratio, CNR) of the 37-mm sphere as a
function of the number of equivalent iterations in SPECT/CT images with CT
attenuation and background compensation (solid blue line). The red square indicates
the CNR of the sphere for SPECT/CT images with CT attenuation correction only at
convergence. (right) Transaxial and coronal images of the IEC phantom: (a)
attenuation-corrected and background-compensated at the highest CNR (37-mm
sphere), (b) attenuation-corrected and background-compensated at convergence (3735

mm sphere), and (c) attenuation-corrected at convergence. Attenuation correction
and background compensation improved detectability [(b) versus (c)]. The highest
detectability was achieved before convergence [(a) versus (b)]. In (b), the SBR was
about 7, whereas the SBR in (c) was only about 3. SUB: subset, IT: iteration

2.4.

Discussion

2.4.1.

Limitation of the proposed background-compensation method
The proposed BC method is an empirical model. Monte Carlo simulation studies are

required to accurately correct for specific components of scatter in the imaging EW. For
example, Monte Carlo simulation studies[11,12] suggest that EW F (315–415 keV) may
contain little or no object scatter information. Although our proposed BC method was not
designed to correct for any specific source of contamination in the imaging EW B (e.g.,
object scatter, septal penetration, septal scatter, backscatter), we have shown that the
proposed method increased both the CNR (detectability) and the accuracy of activity
quantification.
The BC factor was derived for a Siemens Symbia T gamma camera with a 1.6-cm
crystal and MELP collimator. Since energy window-based scatter correction is dependent on
the energy spectrum, other makes and models of cameras with different crystal thicknesses
and collimators will likely require different BC parameters, i.e., EW selections and BC
scaling factors. The methodology described here, however, could be applied to develop BC
models for 90Y bremsstrahlung SPECT/CT imaging using other SPECT/CT systems. The
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readers are encouraged to use the procedure outlined here to determine the BC factors on
their own systems prior to the clinical implementation of this technique.

2.4.2.

Energy window selection
The signal-to-background ratio the highest in EWs A and B (and perhaps even C),

which means that these EWs provided more spatial information in the image than did the
other EWs. This finding is consistent with other studies that found that the optimal EW for
qualitative 90Y bremsstrahlung imaging was 80–180 keV.(54, 60) However, EW A was
contaminated by the characteristic X-rays (70–90 keV) from the lead collimator and lead
housing, so we chose EW B (the EW with the highest SBR) as the imaging EW of the 90Y
bremsstrahlung images.
However, the BC EW was chosen empirically based on the SBR recovery, as shown
in Fig 5. Since EWs A and C had signal-to-background ratios comparable to that of EW B—
that is, they contained good spatial information—using these EWs to compensate for
background yielded a decrease in SBR recovery compared to using no BC.
To further validate our empirical method, two line profiles were extracted from the
static images in EW B and EW F (Fig 10). One line profile was extracted across an image of
a liver and the other one was drawn in the background region. The line profiles of the liver
images showed that EW B provided much more spatial information of the liver image than
did EW F. The line profiles in the background region suggest that the spatial distributions of
the background signal were similar in EW B and EW F, supporting the usefulness of the
proposed BC mode to compensate for the background signal.
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Fig 10. The images on the top are clinical images from Fig 6 in energy window (EW) B
(left) and F (right) showing the locations from which the line profiles were extracted.
The graphs at the bottom show line profiles in EWs B and F (scaled) across the liver
image (left graph) and line profiles of EWs B and F (scaled) across the background
region outside the liver (right graph). In the regions outside the liver (shaded), the
background profiles in EWs B and F (scaled) are indistinguishable.

2.4.3.

Partial volume effect and bremsstrahlung 90Y quantitative accuracy
Yttrium-90 bremsstrahlung imaging using current commercially available gamma

camera is hardware limited. The collimators used for nuclear medicine imaging are not
designed for such high energy (up to 2.3 MeV) bremsstrahlung photon spectra of 90Y. The
observed events in the gamma camera have high contaminations from photons that have
undergone septal penetration, septal scatter and backscatter that contribute to low image
contrast. Furthermore, bremsstrahlung imaging has an inherent poor resolution due to
electron staggering (up to 11 mm in soft tissue) in the bremsstrahlung production. These
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limitations may be addressed by optimizing(61, 62) the gamma camera collimator design for
90

Y bremsstrahlung imaging and by incorporating the physics model of electron staggering

and bremsstrahlung photon generation in 90Y SPECT/CT reconstruction using Monte Carlo
simulation(27, 28, 63).
In order to minimize the interplay of the partial volume effect when assessing
SPECT convergence, we used a VOI with 10-mm diameter to assess the recovery of activity
concentration for the 37-mm sphere. As a result, up to 90% of the activity concentration in
the 37-mm sphere was recovered at convergence. Qualitatively, as seen in Fig 9, spheres
with diameter below 22 mm were not clearly visible in reconstructed 90Y SPECT/CT images.
As shown in Fig 11, the closer the VOI diameter is to the nominal diameter of the 37-mm
sphere, the lower the recovery coefficient. Due to the partial volume effect, when using a
VOI that matches the 37-mm sphere size, the recovery coefficient of 55% was realized.
However, matched VOIs between CT and SPECT are needed for tumor dosimetry.
Therefore, use of various published techniques to compensate for the partial volume effect
will need to be employed for tumor dosimetry in clinical practice(64, 65). In contrast, the
partial volume effect in 90Y PET/CT is less pronounced. Recent 90Y PET/CT quantitative
studies(66, 67) have suggested that the recovery coefficient of 90% is achievable in a 37-mm
sphere using a matching VOI size.
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Fig 11. Graph of signal-to-background ratio recovery as a function of the diameter of the
volume of interest (VOI). The SBR recovery decreases as the VOI diameter increases,
demonstrating the partial volume effect.

2.4.4.

Count-to-activity calibration factor derivation
The unique imaging conditions of 90Y microsphere therapy permit SPECT/CT

counts-to-activity calibration for generating quantitative 90Y SPECT/CT images to be
performed using clinical 90Y images. SPECT images with CT AC + BC can be used to
accurately quantify the activity present in the FOV with a mean absolute deviation ≤ 4%.
Because the calibration factor determined using the IEC phantom demonstrated a substantial
bias, caution is warranted when using an IEC phantom to calibrate SPECT/CT systems, since
it may not accurately represent clinical imaging conditions in terms of attenuation and
scatter.

40

2.4.5.

Reconstruction parameter optimization
For OSEM reconstruction, the background noise also increases as a function of the

number of equivalent iterations (Fig 8); therefore, the highest detectability (as measured by
CNR) is usually achieved before the convergence (Fig 11). At convergence, even though the
image quantification is more accurate, image detectability may actually be lower.

2.4.6.

Correction for deadtime count loss
Because the yield of bremsstrahlung radiation in adipose and soft tissue (low-Z

material) with a high energy spectrum is low, the number of detected photons is low; hence,
gamma camera deadtime count loss is not an issue for post-therapy 90Y SPECT/CT imaging.
The number of total counts per activity was found to be linear (at least in the activity range of
1–5 GBq), providing further confirmation that the gamma camera does not suffer from
deadtime count loss. If, however, correction for deadtime count loss is needed, the recently
proposed revised monitor source method for practical deadtime count loss compensation can
be employed. (68, 69)

2.5.

Conclusion
We have proposed a practical method to reconstruct quantitative SPECT images

with CT attenuation correction and empirical EW-based BC. For Siemens SymbiaT
SPECT/CT systems, we found that EW B (90–130 keV) and EW F (310–400 keV) are the
most appropriate to be used as the imaging and BC EWs. Despite our empirical correction
method’s limitations, our phantom study shows that our reconstruction and compensation
method improves both image quality and quantification.
41

Acknowledgments: Supported in part by Siemens Medical Solution USA and the NIH
National Cancer Institute grant R01CA138986.

42

Chapter 3: Quantitative 90Y-PET image reconstruction: optimization

3.1.

Introduction
90

Y microspheres have been used for treating non-resectable liver cancer (48, 49).

Current dosimetry standard for 90Y-microspheres treatment planning, as recommended by
AAPM (70) is the schema (71) developed by MIRD dosimetry that assumes uniform
distribution in normal liver, tumor, and lung using partition mode (72) based on the surrogate
99m

Tc-MAA planar images. This simplistic model aims to calculate the mean organ absorbed

dose for safe treatment planning (73).
In diagnosis nuclear medicine imaging, mean organ absorbed dose is the primary
dosimetry metric of interest to evaluate population cancer risk from the imaging procedure.
On the other hand, in (pre and post) therapy imaging, the dosimetry task aims to calculate
normal tissue complication probability (NTCP) and tumor control probability (TCP) for the
individual patient. These two RPT end points require the dose distribution information,
which is beyond mean absorbed dose (40, 74); therefore there is a pressing need for
volumetric dosimetry of 90Y.
In the past decade, volumetric 90Y dosimetry techniques have been implemented
based on 3D 90Y-activity distribution from both bremsstrahlung SPECT/CT (20, 51) and
more recently from PET/CT (21, 35, 75) imaging. It has also been shown that local
deposition method can be used to generate 90Y dose map (Gy) by scaling the PET images
(Bq/mL) using a single conversion factor (Gy/Bq/mL) (22, 35, 51). Since 90Y PET/CT
images have been suggested to have advantages over bremsstrahlung SPECT/CT in term of
image contrast, resolution, and hence quantification ((24–26), in this work, we focus on 90Y
PET/CT to quantify volumetric 90Y dose.
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3D activity distribution that is observed in emission images is subject to image
degrading factors such as partial volume effect, image noise, and motion blur (40).
Consequently, the dose volume histogram calculated from these images (DVH’) suffers from
errors due to these degrading factors. While these degrading factors affect all nuclear
medicine imaging, 90Y PET imaging presents a unique challenge in that it has an extremely
low signal, coming from 32 ppm of positron yield produced via internal pair production.
Several groups have used DVH’ to summarize the information of 3D dose
distribution estimated from 90Y PET images (22, 23, 25). DVH (76) plots in the abscissa the
minimum dose (Dx) that covers x% of the volume of interests (VOI) in the ordinate. The
spread of the DVH curve around the median indicates the non-uniformity of the 3D dose
distribution in the VOI (77). The two aforementioned RPT end points, i.e., TCP and NTCP
can be calculated from DVH (78, 79). In practice, however, calculation of TCP and NTCP
are complicated as they require radiobiological parameters that are difficult to determine
from in vivo studies. Alternatively, empirical dose-response model have been derived by
correlating DVH’ summary metrics such as D95 in external beam therapy, D90 in
brachytherapy, and recently D70 in 90Y-microsphere studies (22, 23, 80–82). Even though
PET/CT images have been increasingly used for volumetric dosimetry calculation, the impact
of signal starvation on the errors, both systematic and random, in the resulting DVH’ and it
summary metric (e.g., Dmean and D70) is poorly understood.
There has not been any standardization of 90Y PET image acquisition and
reconstruction. Recent studies on OSEM reconstruction-parameters optimization for
quantitative 90Y PET imaging (24, 36–39) still used mean-activity-concentration recovery
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coefficient as the objective function, which is more relevant to diagnostic dosimetry and
detection tasks.
In this work, we aimed to optimize 90Y-PET image-reconstruction protocol for
volumetric 90Y dosimetry—calculated as DVH’. We optimized the image-reconstruction
protocol in a phantom studying using a modified NEMA IEC phantom study under a wide
range of clinically relevant imaging condition: sphere sizes, activity concentrations, sphereto-background ratios, and acquisition durations. While increase in equivalent number of
iterations improves image resolution and quantification of mean activity concentration, it also
increases the image noise. After convergence is achieved, increase in equivalent number of
iterations only results in higher image noise. Application of Gaussian post-reconstruction
filtration introduces image blurring and it can be used to reduce image noise; although it
results in underestimation of the mean activity concentration with severity degree depending
on the filter full width half maximum. Image noise and partial volume effect are major
degrading factors that limit voxel-based dosimetry (40); hence, optimization of
reconstruction parameters (equivalent number of iterations and post-reconstruction filtration
FWHM) is imperative to improves the accuracy of DVH estimates calculated from noisy 90Y
PET images (DVH’).

3.2.

Methods
We used a modified NEMA IEC phantom (Biodex, Shirley ,NY) to emulate

clinically relevant 90Y PET imaging conditions thru various combinations of acquisition
durations, sphere activity concentrations, sphere-to-background ratios (SBR), and sphere
sizes. The modified IEC phantom contains 2 sphere sets of diameters 37, 17, 13 mm each.
These sphere were filled with 90Y activity concentrations (AC) of 4.8 MBq/cc (130 uCi/mL)
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and 1.6 MBq/mL (43 uCi/mL); the background chamber was filled with 0.4 MBq/mL
(10 uCi/mL) to give SBR of 13 and 4.
PET data of the IEC phantom were acquired in list-mode using GE D690 PET/CT
scanner for 300 min in 1-bed position. To optimize the quantitative image reconstruction,
PET images were reconstructed using various parameter sets. All PET images (AC map in
Bq/mL) were multiplied by a scaling factor of 4.78×10-5 Gy.mL/Bq to convert the PET
images to 90Y dose map (Gy) via local deposition method (35).
To evaluate the variation of optimum reconstruction parameters under a range of
image noise, we replayed the list-mode PET data to 60, 45, 30, 15, and 5 min with 10
different realizations each. We also acquired the PET list-mode data on day 0 (sphere ACs
of 4.8 and 1.6 MBq/mL) and on day 3 (sphere ACs of 2.3 and 0.8 MBq/mL) to assess
variation in reconstruction due to dose rate during acquisition.
The PET/CT images were reconstructed using 3D-OSEM with PSF+TOF
modelling (VPFXS). The voxel size was 2.6 × 2.6 × 3.3 mm3. Assuming local energy
deposition, the corresponding known doses of the sphere sets were 230 and 77 Gy on day 0
and 110 and 37 Gy on day-3 acquisition. We optimized the image reconstruction parameter
using both recovery coefficient (RC) of mean dose (section B.1.1) and minimum errors in
volumetric 90Y dose quantification (section B.1.2) as the objective functions.

3.2.1.

Reconstruction optimization based on recovery-coefficient convergence
The reconstruction parameter optimized in this sub section was the number of

equivalent iterations (subsets × iterations); where the objective function of the optimization
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was recovery coefficient (RC) of mean sphere dose. PET images were reconstructed using
fixed subset of 12 and varying iterations of 1–12.
The sphere RCs were calculated as RC = Dmean/Dtrue; where Dmean is the mean dose
in the sphere computed from CT-contoured VOI, and Dtrue is the known absorbed dose in the
sphere calculated based on the injected 90Y activity.
The convergence properties of sphere RC were evaluated under aforementioned
various imaging conditions: acquisition durations (300–5 min), sphere dose (230–37 Gy),
SBR (13 and 4), and sphere sizes (37, 17, and 13 mm). RC convergence was determined by
calculating sphere RC as a function of number of equivalent iterations for images with no
post-reconstruction filtration.

3.2.2.

Reconstruction optimization based on errors in dose volume histogram

estimates
Here, the reconstruction parameters optimized were both the number of equivalent
iterations and the full width at half maximum (FWHM) of the post-reconstruction Gaussian
filters. PET images were reconstructed using fixed subset of 12 and varying iterations of 1–
12. The post-reconstruction Gaussian filters in the transaxial plane were varied from 0, 2.6,
5.2, 7.8, and 10.4 mm. The PET images (Bq/mL) were converted to dose map (Gy) and were
corrected for dose-dependent systematic error in volumetric 90Y dose (Chapter 4).
We optimized the image-reconstruction parameters for sphere (tumor) dose
quantification; therefore the volumetric dose distribution in the all sphere sets (13, 17, and
37-mm spheres with SBR of 13 and 4) were quantified using dose volume histogram estimate
(DVH’). The optimization objective function was minimum errors in the sphere DVH’.
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Sphere DVH’ were derived from matching-sized volumes of interest (VOI) that were
contoured from CT sphere images, e.g., DVH’ in the 17-mm sphere was derived from 17-mm
spherical VOI. Errors in the DVH’ were calculated as root mean square errors (RMSE) of
the differences in the image-based sphere DVH’ and the true DVH, i.e., 𝑅𝑀𝑆𝐸 =
2
∑80
20(𝐷𝑥 −𝐷𝑡𝑟𝑢𝑒 )

�

60

; where Dx is the minimum dose that covers x% of the VOI, and Dtrue is the

known dose based on injected 90Y activity. The true DVH was calculated for uniform sphere
dose distribution as such that Dx for all volume coverage, x, equal to Dtrue. RMSEs were
calculated from D80 to D20 to avoid high errors near the maximum (D0) and minimum (D100)
doses due to both systematic and random errors (section C.3.). RMSE for each sphere DVH’
was calculated as an average of 10 different image noise realizations; the standard errors
were also reported. RMSE was calculated for all image-reconstruction-parameter
combinations (equivalent iterations and filtration FWHM) under the same variation of
imaging condition in section 3.2.1.

3.3.

Results

3.3.1.

Reconstruction optimization based on recovery-coefficient convergence
The convergence rates of VPFXS algorithm were found to be insensitive to various

imaging conditions tested: sphere sizes, SBR, sphere dose (activity concentration), and
acquisition duration. Fig 12 demonstrated this convergence rate invariance for sphere with
SBR of 13, sphere diameters of 37, 17, and 13 mm, and sphere dose of 230 and 77 Gy.
Spheres with various imaging condition achieved RC convergence after 36 equivalent
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iterations. The systematic and random errors in converged RC were characterized in
Chapter 4.

Fig 12. Mean dose recovery coefficient (RC) plotted as a function number of equivalent
iterations (subset × iterations) for sphere with sphere-to-background ratio of 13, sphere sizes
of 37, 17, and 13 mm, and dose levels of 230 and 77 Gy.

3.3.2.

Reconstruction optimization based on errors in DVH’
We found that images reconstructed using equivalent iterations of 24–48 and

filtration FWHM of 5.2–7.8 mm, RMSE of sphere DVH’ were consistently among the lowest
in various tested imaging conditions.
Fig 13 shows the DVH’ for 17-mm sphere images (SBR of 13, dose of 230 Gy,
duration of 30 min) reconstructed using various equivalent iterations (Fig 13A) and various
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filtration FWHM (Fig 13B). Their RMSE of DVH’ are shown in Fig 13C as a function of
equivalent iterations and filtration FWHM. The standard errors of selected DVH’ RMSE are
also shown as the error bars. RMSEs of DVH’ were among the lowest at 36 equivalent
iterations; further increase in the number of equivalent iterations beyond 36 resulted in higher
noise, as evident in the increase spread of DVH’ (longer tails on both ends). Similarly, the
RMSE of DVH’ was the lowest with filtration FWHM of 5.2 mm. Heavier filtration shifted
the DVH’ toward lower dose and resulted in higher underestimation of DVH’.
The DVH’ RMSE in a larger sphere image (37 mm in diameter) was the lowest at
equivalent iteration of 24, while the RMSE in a smaller sphere image (13 mm in diameter)
was the lowest at 48 equivalent iterations. However image reconstruction of all spheres
(diameter of 37–13 mm) using 36 equivalent iterations resulted in change of absolute errors
in DVH’ of < 1% at all volume coverage (Fig 13A and Fig 13C).
As the sphere image noise/non-uniformity increases due to lower dose or shorter
duration, 7.8-mm filtration resulted in lower RMSE of DVH’ than did images with 5.2-mm
filtration. Changes in 17-mm sphere (77 Gy) DVH’ calculated from sphere images (15-min
duration) with 5.2 and 7.8-mm filtration were < 3% at volume coverage between 20–80%, on
average.
While application of image filtration suppresses image noise and hence reduces
noise-dependent errors in DVH, it also increases the errors in DVH due to increased partial
volume effect. Heavier filtration with FWHM of 7.8 and 10.4 can be used on larger sphere
(37-mm sphere), where partial volume effect is less severe, to further reduce the RMSE of
DVH estimate; heavier filtration beyond 7.8-mm FWHM, however, did not significantly
improve the DVH’ (< 2% absolute change at all volume coverage). In contrast, application
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of filtration with FHWM wider than 5.2 mm increased the RMSE of DVH’ in smaller
spheres, e.g. in 17-mm sphere (Fig 13B and Fig 13C).
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Fig 13. Dose volume histogram estimates (DVH’) of 17-mm sphere (230 Gy) calculated
from 15-min sphere images reconstructed with (A) equivalent iterations of 12–48 (filtration
full width at half maximum [FWHM] of 5.2 mm) and (B) from images reconstructed with
FWHM of 2.6–10.4 mm (equivalent iteration of 36). The black curve indicates the adjusted
reference DVH. (C) The root mean square error (RMSE) of DVH’ as a function of
equivalent iterations and filtration FWHM for 17-mm sphere image (230 Gy, 15 min).

3.4.

Discussion

3.4.1.

RMSE dependence on dose threshold selection
To determine the sensitivity of RMSEs to selection of dose threshold ranges, we

also investigated the random error in RMSE trends as a function of dose threshold ranges: D0
– D100, D10 – D90, D20 – D80, D30 – D70, D50 – D80, D60 – D90. As expected, using the entire
dose threshold range from D0-D100, the RMSE was the lowest when using lower number of
equivalent iterations to avoid high errors due to noise near the extreme doses. The resulting
DVH, however, yields higher errors in more useful dose metrics, e.g. D20-D80, as shown in
Fig 13 and Fig 14. RMSE calculation using other dose threshold ranges between D10-D90
results in similar RMSE trend as a function of equivalent iterations, i.e., RMSE was the
lowest at 36 equivalent iterations with 7.8-mm filtration (Fig 14). We chose dose threshold
range of D20-D80 as a conservative approach to avoid noise-related errors near the extremes,
which cause both high errors (Fig 13) and high random error (Fig 21A).
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Fig 14. Root mean square errors (RMSE) of 17-mm sphere (110 Gy) dose volume histogram
(DVH) estimate for various dose threshold ranges. Using the entire range D0–D100 results in
an optimization systematic error where low number of equivalent iterations is preferred to
avoid high errors due image.
3.4.2.

Comparison of optimization objective functions: traditional mean dose RC

versus DVH’ RMSE.
As the numbers of equivalent iterations increases, the sphere images begin to
converge, but the image noise increases as well. Transaxial filtration can be used to reduce
the image noise, but it blurs the image, which results in changes in dose distribution
(smeared) with degree of severity depending on the FWHM of the filtration and the sphere
sizes.
Optimization using mean dose RC does not take into account the alteration in dose
distribution due to changes in image noise: increase noise from higher number of equivalent
iteration and reduced noise from higher filtration FWHM. Since spatial filtration reduces the
mean dose RC, reconstruction-parameter optimization using mean dose RC as the objective
function would suggest minimum filtration. As shown in Fig 13, sphere images with no/low
filtration resulted in higher errors in DVH.
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While the standard deviation of the mean dose RC can be used to minimize the
increase noise from higher number equivalent iteration, it cannot be used to optimize the
FWHM of the filtration. Wider FWHM filtration will monotonically result in lower standard
deviation.
Although in clinical practice, post-reconstruction filtration is usually applied to 90Y
PET images, the FWHM of the filtration is not being optimized for volumetric quantification
task. Post reconstruction filtration is normally considered to improve detection only. In this
work, we showed that filtration can be used to improve volumetric quantification; therefore
for volumetric quantification task, the FWHM of the filtration applied to the 90Y PET
images need to be optimized (or verified) based on minimum errors in the DVH.

3.4.3.

Study limitation
This study was limited to phantom studies using a modified NEMA IEC phantom.

Spheres with uniform dose were not true representations of heterogeneous 90Y-microsphere
distribution in the tumor. Future studies using a physical phantom (83) with inhomogeneous
90

Y distribution are needed to further evaluate the errors in volumetric 90Y dosimetry

calculated from 90Y PET images.

3.5.

Conclusion
Using DVH’ as an objection function allows optimization of both number of

equivalent iterations and FWHM of the post-reconstruction filtration. We recommend using
36 equivalent iterations with 5.2-mm filtration for 90Y-PET image reconstructed using
VPFXS (GE OSEM with TOF and PSF).
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Chapter 4: Quantitative 90Y-PET image reconstruction: systematic (bias) and random
(variability) errors.

4.1.

Introduction
This chapter is a continuation from Chapter 3, where we used the optimized image-

reconstruction protocol discussed in Chapter 3 to generate 90Y dose map of the modified IEC
phantom. In this chapter, we characterized the systematic and random errors in the resulting
sphere DVHs’. We evaluated the dose-dependent systematic error in quantitative 90Y PET
images (in GE D690/D710) that have been reported by several groups on different PET
scanner makes and models (37, 39, 66, 84). Then we assessed the unique challenge in 90Y
PET, i.e., very low signal acquired. Low signal introduces increased non-homogeneity
(image noise) in dose distribution, resulting in systematic error in DVH’. In addition, low
signal also increases the random errors in DVH’ measurement, both of which contribute to
total error in DVH’, consequently reducing the predictive value of dose-response model.
In clinical practice, the dose metrics are calculated from a single measurement (e.g.
PET image set). Dose metrics used to predict tumor response ideally should have very high
correlation to response metric and have low errors (systematic and random) so as to maintain
clinically acceptable predication intervals. These PET based metric with high errors will,
despite their high correlation, will have large prediction intervals; hence we need to trade-off
the degree of correlation and the errors in the dose metric used.
Mean tumor dose (Dmean) has been shown to have correlation with tumor response
(73, 85). However, in tumor with heterogeneous dose distribution, the correlation between
mean dose and response will be weaker. Minimum dose (D100) to tumor, in principle, would
have the highest correlation with tumor response. Minimum dose, however, is prone to
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errors (contouring uncertainty, noise in image-based dosimetry, etc). Due to this uncertainty
in minimum dose, dose metrics will less errors (despite lower correlation, theoretically) are
being used in radiation oncology (for example, D95 in external beam therapy, D90 in
brachytherapy). Therefore, accurate measurement of DVH for 90Y therapies are needed and
then those metric need to be correlated with response to establish the appropriate dose metric
for SIRT; there are some suggestions that D70 is of clinical relevance in 90Y SIRT.
The correlation between dose and response metrics require clinical data, which we
currently do not have. Errors in the dose metrics, however, can be studied in phantom study
acquired under clinically relevant imaging condition. In our study, we characterized the
errors of dose volume histogram (DVH) metrics at volume coverage of 20–80% and Dmean,
depending on the noise level, is at D20–D50%. The findings in our study will help future
study by providing some reference 1) in calculation of sample size needed to determine
statistically meaningful dose-response model, and 2) in the confidence interval of dose
metrics calculated from a single measurement (from patient images/dose map). Information
about the overall errors of the dose metrics can be used as a reference to compare the
predictive power of different dose-response models (e.g., Dmean -response vs D80response).

4.2.

Methods
We used a modified NEMA IEC phantom (Biodex, Shirley ,NY) to emulate

clinically relevant 90Y PET imaging conditions thru various combinations of acquisition
durations, sphere activity concentrations, sphere-to-background ratios (SBR), and sphere
sizes. The modified IEC phantom contains 2 sphere sets of diameters 37, 17, 13 mm each.
These sphere were filled with 90Y activity concentrations (AC) of 4.8 MBq/cc (130 uCi/mL)
58

and 1.6 MBq/mL (43 uCi/mL); the background chamber was filled with 0.4 MBq/mL
(10 uCi/mL) to give SBR of 13 and 4.
PET data of the IEC phantom were acquired in list-mode using GE D690 PET/CT
scanner for 300 min in 1-bed position. To optimize the quantitative image reconstruction,
PET images were reconstructed using various parameter sets in section B.1. For the rest of
the study (section B.2.—B.3.), all PET images were reconstructed using the optimal
parameter set derived in section B.1.
All PET images (AC map in Bq/mL) were multiplied by a scaling factor of
4.78×10-5 Gy.mL/Bq to convert the PET images to 90Y dose map (Gy) via local deposition
method (35).

4.2.1.

Dose-dependent systematic error in volumetric 90Y-dose quantification
To separate the errors due to prompt rate and prompt count, we compared the errors

in mean dose as the 90Y activity decayed (rate and count effect) to the errors as the
acquisition duration decreased (count effect only). We acquired 300-min list-mode PET data
of the modified 90Y IEC phantom for 11 consecutive days. As the 90Y activity decayed, both
the total prompt rate and the total prompt counts decreased. We also down-sampled the 300min list-mode data to shorter duration: 120, 60, 20, 10, 5 min. For images with 60–5min
duration, we down-sampled them at 10 different noise realizations.
For all images, the mean dose (with no partial volume effect [PVE]), Dmean, no PVE,
was computed as the mean dose in 37-mm sphere images calculated using a 17-mm VOI to
minimize PVE and random error due to VOI placement. We also computed the mean dose in
the background region as an average of Dmean, background from 5 17-mm VOIs scattered in the
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background region. The errors in Dmean, no PVE and Dmean, background were calculated with respect
to Dtrue, i.e., 1 − Dmean,no PVE /Dtrue . For the 300-min images at different dose level

(different days), we used polynomial data fitting to model the errors as a function of Dtrue for

mean dose in both 37-mm spheres (SBR of 13 and 4) and the background. This empirical
model was used to correct for the dose-dependent systematic error in Dmean, no PVE . We
quantified the errors in DVH’ calculated from sphere dose distribution with and without the
empirical dose-dependent systematic error correction.
For the images with reduced durations, we only characterize the errors as a function
of Dtrue for mean dose in 37-mm spheres with SBR of 13. The errors were calculated as an
average of errors in 10 noise realizations, and their standard errors were also calculated. The
relationships between the errors in Dmean, no PVE and the known dose were compared in both
activity decay and acquisition duration reduction using linear regression method.
The volumetric dose distributions of spheres with different activity (dose) level but
comparable number of true prompt event were compared to assess if there were alteration in
the dose distribution beyond the systematic error in Dmean, no pve. We selected several 37-mm
sphere images at different dose levels (e.g., 230, 100, 11 Gy) and we matched the number of
true prompt event level by varying the acquisition duration (e.g., 15, 30, 300 min,
respectively) such that the product dose and acquisition duration were comparable. The
DVH’ of these 37-mm sphere images were calculated from 17-mm VOI and normalized such
that the area under the curve equaled to unity. Agreement of the normalized DVH was
measured as the (max-min)/average at all volume coverage, i.e., D0 to D100.
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4.2.2.

Comparison between 90Y and equivalent 18F studies
A total of 111 kBq (3 µCi) of 18F was injected into the modified IEC phantom (SBR

of 11 and 3) to simulate the inherent low count and high random fraction (random event/total
prompt) typical of 90Y studies.

18

F activity of 3 µCi resulted in positron emission rate of

108 kcps, which was equal to the positron rate from 3.37 GBq (91 mCi) of 90Y activity. PET
list-mode data of this 18F phantom were acquired for 12 hours and were down-sampled to 12
× 30-min separated by 1 hour each. The 300-min PET-list mode data (day 1 to day 11) for
similar 90Y phantom study were down-sampled to 10 contiguous 30-min scans to match the
scan duration for 18F.
All 18F PET images were reconstructed using the same optimized parameters used
to reconstruct 90Y PET images (section B.1.). At each time point, we calculated the mean
absorbed dose, Dmean, no pve, in 37-mm sphere (SBR 11) from 17-mm VOI and we also
calculated their errors with respect to the known dose from assay. Errors in Dmean, no pve were
characterized as a function of known positron emission rate and compared to the errors in
Dmean, no pve from 90Y study using linear regression analysis to determine the correlation
between the errors and the positron emission rate (activity). In addition, we also compared
the total prompt and number of random events (retrieved from the DICOM tags) in both 18F
and 90Y studies as a function of positron emission rate.
To measure the contribution of internal background radiation from lutetium-176
yttrium orthosilicate (LYSO) crystal, we acquired an 8-hour blank scan of the background
radiation with just air in the FOV. The number of random events in 30-min acquisition was
calculated to match the acquisition duration of 18F and 90Y studies.
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4.2.3.

Impact of low signal on volumetric 90Y dose quantification
To investigate the impact of low signal acquired on accuracy and random error of

the sphere DVH’, we varied the number of true event acquired by reducing the acquisition
duration. The 300-min list-mode PET data were down-sampled with multiple noise
realizations to 5 × 60 min, 6 × 45 min, 10 × 30 min, 10 × 25 min, 10 × 20 min, 10 × 15 min,
10 × 10 min, 10 × 5 min. PET images were reconstructed using optimized reconstruction
parameters for post-therapy quantitative 90Y PET imaging (Chapter 3). The PET images
were converted to dose map and were corrected for dose-dependent systematic error (Chapter
4.2.1)
4.2.3.1. Impact of image noise on volumetric 90Y dose quantification accuracy
The impact of noise in accuracy of both differential (more intuitive approach) and
cumulative dose histogram estimates (DVH’) were evaluated in sphere images with minimal
PVE. VOI with 17-mm diameter was used to calculate DVHs’ in the 37-mm sphere (SBR
13, 230 Gy) images with various durations. At each duration, the DVH’ were calculated as
averages of multiple noise realizations. The magnitude of errors in DVH’ due to noise
(minimal PVE) were compared to the errors from PVE (low noise). DVHs’ were calculated
from the 300-min sphere images (low noise) for both 37- and 17-mm using VOI with
matching sizes to appreciate the PVE.
DVH’ accuracy in clinically relevant imaging condition was evaluated in the
presence of both PVE and image noise. The 300-min list-mode PET data (11-consecutive
day acquisition) were down-sampled to 10 × 30 and 10 × 10 min for each day, spanning
known sphere dose of 11–230 Gy. The tumors were emulated using the 37- and 17-mm
spheres. Sphere DVH’ were calculated as an average of 10 noise realizations and were
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calculated using matching-size VOI. DVH’ accuracy were characterized as a function of
known dose at Dmean, D80, and D20 for both sphere sizes and acquisition durations.

4.2.3.2. Impact of low signal on volumetric 90Y dose quantification random error
We evaluated the data from Chapter 4.2.3.1. The random error of the DVH’ was
calculated as the coefficient of variance (COV = standard deviation/average) of Dx for all
volume coverage, x, in10 noise realizations. We calculated the COV of Dx in 37- and 17-mm
sphere images acquired for 30 and 10 min. The maximum COV of Dx (for 20 ≤ x ≤ 80) was
characterized as a function of known dose.

4.3.

Results

4.3.1.

Dose-dependent systematic error in volumetric 90Y-dose quantification
We observed a non-linear relationship between known dose and measured

volumetric dose quantification in both spheres and background VOI. Fig 15A shows
measured Dmean,no pve in 37-mm spheres and background region as a function of known Dtrue.
Dmean, no pve in both spheres and background VOI showed quadratic relationship (0.0005x 2 +
0.72x − 1.42) with the Dtrue; where x is decay corrected Dtrue. Consequently, the errors in
measured Dmean, no pve, calculated as Dmean, no pve/Dref -1, showed dose-dependent systematic

error that was consistent with quadratic relationship, i.e., (0.0005x + 0.72 − 1.42/x), shown
in Fig 15B. In contrast, the errors in Dmean, no pve calculated from sphere images with reduced

duration did not exhibit noise-dependent errors (Fig 15C). The standard errors of the errors
in Dmean, no pve for 60 to 5-min images were < 0.5%, shown but not visible in Fig 15C. The
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slope of the errors vs. fractional count (duration) was consistent with zero with p value >>
0.05, while the slope of the errors vs. fractional count (activity) was clinically significant
with p value << 0.05.
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Fig 15(A) Measured mean absorbed dose Dmean, no pve (with minimal partial volume effect) in
sphere and background regions as a function of known dose (from assay) showing a
quadratic relationship. (B) The errors in Dmean, no pve as a function of known dose showing an
dose-dependent errors in Dmean, no pve. (C) Comparison of error trends in Dmean, no pve of 37-mm
sphere (SBR 13) vs. fractional count. The fractional count is varied by reducing the
acquisition duration (orange line) and by letting the activity decay (red line).

The alteration in volumetric 90Y-dose quantification due to this dose-dependent
systematic error was found to be scalar, i.e., the relative dose distribution was not varied by
this dose-dependent systematic error, as evident in the agreement in normalized DVH’ of
sphere images at different dose level (different errors) with equivalent noise. Fig 16A shows
that the normalized DVH of 37-mm sphere with dose of 230, 100, and 11 Gy agree within
4%, which was consistent with their measurement random error (Chapter 4.3.3.2.). The
dose-dependent errors in Dmean, no pve were -20%, -24%, and -34% for sphere dose of 230, 100,
and 11 Gy, respectively.
Fig 16B shows the DVH’ (minimum partial volume) of 37-mm sphere (known dose
of 110 Gy) for acquisition duration of 30 min with and without correction for dose-dependent
systematic error. After the correction for the dose-dependent systematic error, the error in
Dmean, no pve was reduced from -22% to +2%; while the error in D80 was reduced from -36% to
-15%. The overestimation in Dx for volume coverage x >50% was consistent with the
systematic error introduced by the image noise (Chapter 4.3.3.1).
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Fig 16. (A) Agreement between normalized dose volume histograms estimate (DVH’)
calculated from 37-mm spheres images (17-mm volume of interest) with comparable image
noise, i.e., equivalent number of true coincidence (dose rate × acquisition duration). (B)
DVH’ before and after correction for dose-dependent systematic error.
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4.3.2.

Comparison between 90Y and equivalent 18F studies
Dose-dependent, which were seen in 90Y study, were not observed in 18F study with

equivalent positron emission rates. Fig 17A shows errors in Dmean, no pve as a function of
positron emission rate (or equivalent 90Y activity) for both 18F and 90Y studies. The errors in
18

F had higher uncertainty due to their single 30-min acquisition duration compared to 10

repeat scans of 30-min acquisition for each 90Y data point. The correlation of the errors and
positron emission rate in 18F study was not clinically and statistically significant with slope of
0.0006 and p-value of 0.5. In contrast the errors in Dmean, no pve and positron emission rate had
strong correlation with slope of 0.07 and p-value of 0.007.
At clinical 90Y equivalent positron emission rate, the random fraction (random
events/total prompt) in both 90Y and 18F data were very high. Fig 17B shows that the random
events dominated the total prompts in both 90Y and 18F studies. The number of random
events in 90Y data, however, was higher than it was in 18F data with equivalent number of
true coincidence.
Because of the very low PET signal (low positron emission rate), the random events
associated annihilation photons are low as well. Fig 17B shows that the number of random
events in 18F data was dominated by LYSO background; as the positron emission rate
(activity) increased from 2 to 75 kcps, the number of random events only increased from 1.50
to 1.53 Mcount. On the other hand, the major contributors to the number of random events in
90

Y data were LYSO background and bremsstrahlung photons. The number of random

events increased from 2.34 to 4.95 Mcounts as the positron emission rate increased from 4 to
75 kcps (0.13 to 2.36 GBq 90Y). The number of random events due to LYSO background
was calculated to be 1.55 Mcount in 30-min blank scan, which was consistent with zero
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extrapolation from random events in 18F study. In contrast, there seemed to be an
overestimation in the LYSO background contribution in 90Y data; zero extrapolation from
random events in 90Y was 2.13 Mcount.

Fig 17 (A) Errors in mean dose of 37-mm sphere image (calculated using 17-mm volume of
interest) as a function of positron emission rate (or equivalent 90Y activity) for both 18F and
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90

Y in similar phantom studies. (B) Number of coincidence events in the scanner FOV as a

function of positron emission rate from 18F and 90Y phantom studies in (A). Note: P: total
prompt, R: random coincidence, T+S: true + scatter coincidence
4.3.3.

Impact of low signal on volumetric 90Y dose quantification

4.3.3.1. Impact of image noise on volumetric 90Y dose quantification accuracy
We observed that the low count acquired in PET data increased the non-uniformity
(image noise) in the dose distribution. Due to the non-negativity constraint of the voxel
values in the image-reconstruction algorithm, the observed dose distribution was positively
skewed, i.e. the dose distribution had a long tail toward high dose while the mass of the
distribution was concentrated on the lower dose, as shown by the differential dose histogram
in Fig 18A for 37-mm sphere (minimal PVE, reference dose of 60 Gy) under multiple
acquisition durations. The degree of skewness, calculated as Pearsons’ 2nd skewness
coefficient, increased as the image noise increased (with shorter acquisition duration and/or
lower dose). The Dmedian had increased negative deviation from Dmean as the acquisition
duration was reduced, Fig 18B. Image noise introduced errors in the sphere DVH estimate as
shown in Fig 18B for 37-mm sphere with known dose of 230 Gy. Away from the average
dose (Dmean) the DVH metrics (Dx) toward the minimum dose (D100) were underestimated
and toward the maximum dose (D0), Dx were overestimated.
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Fig 18. (A) Images of modified IEC phantom acquired for 300, 20, and 5 min. The sphere
doses are 230 and 77 Gy with SBR of 13 and 4, respectively. (B) Differential and (C)
cumulative volume histogram in 37-mm sphere image acquired for multiple acquisition
duration. The histograms were calculated using 17-mm volume of interest to minimize
partial volume effect.
Fig 19 shows the DVH’ of the 17-mm sphere with PVE, and DVH’ of the 37-mm
sphere with and without PVE. The sphere dose was 230 Gy and the images were acquired
for 300 min (solid lines) and 10 min (dash lines). With minimal PVE, the magntidue of
errors in D80 increased from -3.4% to -22.7% when the acquisition duration was reduced
from 300 to 10 min. The errors in Dmean, no PVE were relatively insensitive to noise, the errors
increased from -0.2% to -2.5% as the duration was reduced.
PVE caused underestimation in DVH’ at all volume coverage (Fig 19). The errors
in Dx were higher toward minimum dose, i.e., when the volume coverage (x) was high. The
errors in 37-mm sphere DVH’ calculated from 300-min sphere images were -29.7%, -12.5%
at D80, and Dmean, respectively; whereas the errors in 17-mm sphere (300 min) DVH’ were -55.4%, -32.4% at D80, and Dmean, respectively.

The confounding errors from image noise

were minimal in the DVHs calculated from 300-min images: < 5% between D5 and D95, and
< 10% outside D5–D95. In the presence of PVE, the additional errors due to acquisition
reduction from 300 to 10 min were ~10% and <5% for both 37- and 17-mm sphere. These

additional errors were slightly lower (1%–2%) in 17-mm sphere, which suffered more PVE,
than they were in 37-mm sphere DVH.
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Fig 19. Dose volume histogram (DVH) of spheres with 3 degrees of partial volume effect
(minimum, 17- and 37-mm sphere) and 2 acquisition durations (300 and 10 min).

Fig 20 shows the errors in 17-mm sphere DVH’ (D20, Dmean, and D80) as a function
of known sphere dose for both 30-min (solid lines) and 10-min (dash lines) acquisition
duration. For acquisition duration of 30 and 10 min, the errors in DVH estimates (D20—D80)
between known dose of 60—240 Gy were not sensitive (< 10% change) to changes in dose.
At known sphere dose of < 60 Gy, the magnitude of errors started to increase.
The average errors in DVH’ for 17-mm sphere with known dose of 60—240 Gy
were -8%, -33%, and -57% at D20, Dmean, and D80, respectively, for 30-min scan; while, the
errors in DVH’ calculated from 37-mm sphere images (30-min scan) were +12%, -10%, and
-34%, respectively. At shorter acquisition duration of 10 min, the additional errors in the
DVH estimates for 17-mm sphere images were -10% and -1% at D80 and D20, respectively.
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For DVH estimates of 37-mm sphere images, the additional errors were +5% and +11% at
D80 and D20, respectively.

Fig 20. Errors in D80, D20, and Dmean as a function of known dose for 17-mm sphere. The
solid and dash lines indicate errors in 30- and 10-min acquisition, respectively.

4.3.3.2. Impact of low count on volumetric 90Y dose quantification random error
The COV of DVH estimates was lower in 37-mm sphere and 30-min duration. Fig
21A shows COV of DVH estimates as function of volume coverage for sphere sizes of 37(solid lines) and 17-mm (dash-dot lines) spheres, and acquisition duration of 30 and 10 min.
We found that the COV was the highest around the minimum dose (D80 to D100) followed by
the maximum dose (D0 to D20); whereas between D20 to D80 the COV was the lowest and
stable (< 10% change).
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In clinically relevant tumor dose of 60—230 Gy, the COV (between D20 to D80) of
37-mm sphere DVH estimates was < 5% and < 10% for acquisition duration of 30 and
10 min. For 17-mm sphere DVH estimates, the COV (between D20 to D80) was < 15% for
acquisition duration of 30 min. DVH estimates of the 17-mm sphere that were calculated
from 10-min sphere images suffered from higher random error. At a known sphere dose of
110 Gy, the COV (between D20 to D80) of DVH estimates was already 20%. Fig 21B shows
the maximum COV (between D20 to D80) as a function of known dose.
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Fig 21. (A) Coefficient of variation (COV) in 37- and 17-mm sphere DVH estimates (with
known dose of 230 Gy) calculated from 30- and 10-min images with 10 noise realizations.
(B) Maximum COV (between D20 and D80) in 37- and 17-mm sphere DVH estimates as a
function of known dose. Note: the solid and dash-dot lines represent 37- and 17-mm spheres,
respectively.
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4.4.

Discussion

4.4.1.

Dose-dependent errors in volumetric 90Y dose quantification
We characterized the errors in Dmean, no pve as a function of known dose and

compared them to the errors in Dmean, no pve as a function of duration (Section C.2.1). The
correlation between errors in Dmean, no pve and acquisition duration (fractional count) was
found to be practically (< 1% change in errors going from 300- to 5-min duration) and
statistically (p value of the slope >> 0.05) insignificant; hence suggesting that the errors trend
observed from images with decayed dose level was related to the dose (activity) only and not
related to image noise.
True, scatter, and random contribute to the total prompt acquired. Among these
components, random is the only quadratic component. In this work, the random correction
was done using estimation from singles, i.e., R ≅ S1 S2 ΔT, where R is the random rate, S1 and
S2 are the single rates, and ΔT is the timing resolution. The quadratic relationship (Fig 15A
and Fig 15B) between measured Dmean, no pve suggests that the random was not properly
corrected which resulted in an dose-dependent errors in Dmean,no pve. This hypothesis is also
supported by comparison with 18F study with comparable positron emission rate to 90Y. In
our 18F phantom study, when positron emission rate is < 20 kcps, the random fraction
(random event/total prompt) is >90% (Fig 17B), which is comparable to the random fraction
observed in clinical 90Y study. However, even with similar random fraction, no dosedependent systematic errors were observed in 18F study. Comparison to trace amount of 18F
study suggests that the dose-dependent systematic errors observed in 90Y is caused
predominantly by the imperfect correction of random events from bremsstrahlung photons—
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which is absent in 18F study—rather than from background radiation in the detector from
LYSO crystal, as suggested by previous study (66).
The overall errors in sphere DVH’ that we showed in section C.3.1. were corrected
for the activity-dependent errors. In clinical practice, it may not be possible to correct for
these dose-dependent systematic errors (section C.2.1.) because of the confounding errors in
measured mean dose. Without correction for dose-dependent systematic error, the additional
systematic error in volumetric dosimetry for tumor with average dose of 40–230 Gy is -20%
to -30% (Fig 15B), whereas the systematic error in dose quantification in the normal tissue (<
30 Gy) is ~5–10 Gy.
4.4.2.

Systematic and random errors in quantitative 90Y -PET imaging in clinical

practice
The unique challenge in 90Y PET imaging is that it has a very low signal (32 ppm
positron yield), which introduced systematic errors (Fig 18) and random error (Fig 21), both
of which result in errors in DVH’ (Chapter 4.3.3). Systematic errors in DVH’ due to
increased image noise can be reduced by “minimizing” equivalent iteration and
“maximizing” filtration FWHM (section C.1.2.). Through image reconstruction
optimization, the additional systematic error in DVH’ due to image noise can be kept < 10%
(in addition to > 50% total systematic error) even at low tumor dose of 40 Gy and image
acquisition duration of 10 min (Fig 19 and Fig 20).
The random error in DVH’ measurement can only be reduced by increasing the
signal acquired. For a given PET imaging system, the only adjustable parameter is the
acquisition duration (or table speed in continuous bed motion mode. For GE D690/D710, at
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acquisition duration of 30 min, the random error in measured DVH’ can be kept < 10% even
in 17-mm sphere with low dose (40 Gy); while at acquisition duration of 10 min, the random
error in DVH’ is > 20%. Therefore, to keep the additional errors (systematic and random) in
DVH’ < 20% for a typical tumor in hepatocellular carcinoma (HCC)—equivalent sphere
diameter of > 17 mm and mean tumor dose > 60 Gy—ideally 90Y PET data need to be
acquired for 30 min. In clinical practice, the prescribed scan length for 90Y-microsphere liver
scan is 2 bed positions for majority of the patients; hence scan duration needed would be 2
× 30 min, which will likely be the maximum duration in clinical practice.
At lower count study, e.g. shorter duration and/or lower activity concentration,
the COV is higher toward minimum dose D100. The COV differences of D20 and D80 of up to
10% were observed. For decent statistic (duration of 300 min, dose of 230 Gy), Dmean
approximately equals to D50, however, Dmean is closer to D30 at low statistic (duration of
10 min, dose of 230 Gy). Consequently, the COV in Dmean at low statistic can be up to 10%
lower than D80. The errors in DVH also increase with increase in image noise, a
manifestation of low count data. The magnitudes of errors in DVH are the smallest at Dmean,
whose location in the DVH varies between D20–D50 depending on the image noise, and the
highest toward D0 and D100. In addition, because of the magnitude of the errors in D80 are
higher, the random errors are also higher. Therefore for summary metrics such as D80 or D70
will have higher systematic errors and random errors than Dmean.
Without activity-dependent correction, the measured Dmean in tumor (> 27 mL) PET
images acquired (using GE TOF scanners (D690 and 710, without prompt gamma correction)
will have errors of -20%, -25%, and -30% at measured mean dose of 200, 100, and 50 Gy.
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For tumor with smaller size (e.g. 2.6 mL), the errors are about 10% higher due to partial
volume effect. The uncertainty is < 5% for tumor Dmean of dose > 50 Gy (both 30- and 10min durations).
The underestimation in Dmean is increasing from -30% to -35% when Dmean
decreases from 50 to 10 Gy (dose level relevant to normal tissue). The uncertainty in
Dmean of normal tissue is low (<5%) as well for both acquisition durations of 10 and 30 min
because the volume of interest for normal tissue is usually large (>> 27 mL).
Another consideration for determining the acquisition duration is whether or not to
perform (gating-based) motion correction for liver, which is subject to breathing motion.
With quiescent-period-gating method, the systematic errors in DVH’ in motion-degraded
images can potentially be reduced to < 10% —which is consistent with our finding here
where the additional systematic error in DVH’ due to reduced duration is <10%—at the
expense of increase random error because the images were reconstructed using 33% of the
total counts (effectively reducing the duration by 1/3).
Caution needs to be exercised when comparing dose data from published reports.
Major challenges in comparing dose (Gy) are dosimetry models (standard vs partition vs
image based), input images (PET vs 90Y microsphere bremsstrahlung SPECT vs 99mTc-MAA
SPECT). In our study using GE TOF scanners, we learned that even with the same PETbased dosimetry, the discrepancies in quantification of PET image from different scanner
models (and image reconstruction) makes it difficult to make direct dose comparison. The
errors in Dmean that we reported in GE TOF scanners are different from the errors observed
in Siemens or Philips scanners.
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Going forward, dose reporting needs to include the estimated errors (both
systematic and random) in order to be able to make “Gray” a meaningful unit again. Unless
these errors are reported, we cannot compare the dose value reported in other publications.
The QUEST study by Willowson et al (66) characterized the average systematic
errors in various make and model of PET scanners. This study can be used to translate PETbased dose value.

4.4.3.

Partial volume effect
Partial volume effect (PVE) blur the sphere images, as a result the image (activity

concentration [Bq/mL] distribution) of a uniform sphere is not uniform with the measured
activity concentration higher at the center than at the edge of the sphere image. The PVE is
more severe in sphere with smaller diameter. Due to PVE, the sphere DVH deviates from the
ideal rectangular DVH.
Dose map of a sphere with uniform 90Y activity distribution is not uniform because
the electrons deposit their energy as they stagger in the sphere with average range of 4 mm
and max range of 11 mm. The point at the center of the sphere will have highest dose
because it receives the energy from all the high activity concentration distributed in the
radius of 11 mm. A point at the edge of the sphere will have lower dose because it receive
energy partially from high activity distribution in the sphere and also from low activity
distribution in the background. As a result the dose map is a blurred version of the ideal
uniform sphere image.
Using local deposition method (LDM), the sphere PET image (Bq/cc) is
proportional to the dose map (Gy), i.e., the relative distributions are the same. Both sphere
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PET images and sphere true dose map are a blurred version of the ideal uniform sphere
image; hence the effect of image PVE on dose map calculated using LDM is reduced. The
errors of PET-based dose map (LDM) with respect to the true dose map will be higher if the
PET resolution is much different to the FWHM of the dose-kernel, e.g. resolution in the order
of centimeter or sub-millimeter.

4.4.4.

Study limitation
This study was limited to phantom studies using a modified NEMA IEC phantom.

Spheres with uniform dose were not true representations of heterogeneous 90Y-microsphere
distribution in the tumor. Future studies using a physical phantom (83) with inhomogeneous
90

Y distribution are needed to further evaluate the errors in volumetric 90Y dosimetry

calculated from 90Y PET images.
PVE is the dominant source of systematic errors in DVH’ even in count-limited 90Y
PET images (Chapter 4.3.3). In this work, we did not perform partial volume correction
beyond using PSF correction option in the image reconstruction. Even though application of
post-reconstruction filtration increases PVE, we have shown in section C.1.2 that application
of moderate filtration (5.2-mm FWHM, in this case) results in less systematic errors in
DVH’. Voxel size and z-axis filtration were not evaluated in this work. Both parameters can
potentially be optimized to trade-off the systematic error and random error in DVH’.
Partial volume effects are often compensated (74, 86) using a correction factor ,
which is derived from either simulation or phantom studies, to correct for average voxel
value in a VOI for a given geometry. This empirical partial volume compensation method
can be expanded to correct for underestimation in DVH’ instead of the mean dose alone.
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More advance partial volume correction methods use prior anatomical information
based on co-registered high resolution CT images. Application of this class of partial volume
correction to 90Y quantitative PET imaging is very challenging because there is no biological
uptake of microsphere distribution; microspheres are distributed mechanistically based on the
blood flow in the vasculature, which may not be resolvable in CT images.
We hypothesized that the dose-dependent systematic error originated from
imperfection in random correction of bremsstrahlung photons. Recently, 90Y-PET image
reconstruction algorithms that model the prompt gamma have become clinically available.
Similar phantom studies are needed to determine whether prompt-gamma modelling can
reduce the dose-dependent systematic error in 90Y PET images.

4.5.

Conclusion
Low signal in 90Y PET imaging introduces both systematic and random errors in

volumetric 90Y dose quantification. Using errors in DVH’ as the objective function, the
image reconstruction protocol can be optimized such the additional systematic error in DVH’
due to low signal < 10%. To keep the random error low, 90Y PET data need to be acquired
for as long as reasonably achievable (anti ALARA) duration, especially if motion correction
is to be implemented.
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Chapter 5: Effects of image noise, respiratory motion, and motion compensation on 3D
activity quantification in count-limited PET images

5.1.

Introduction
90

Y microspheres are used for treating non-resectable primary and metastatic liver

cancers (48, 49). Post-treatment 90Y imaging is useful in assessing planned microsphere
delivery and treatment efficacy (21, 81, 83, 87, 88). Unlike most radionuclides used in
nuclear medicine imaging, 90Y is effectively a pure beta emitter, i.e., it lacks discrete-energy
photon emissions, such as gamma and/or characteristic fluorescence X-rays. As a result,
imaging 90Y directly is challenging. The distribution of 90Y activity is traditionally assessed
by imaging the bremsstrahlung photons—produced from interactions of energetic beta
particles with soft tissue—using a gamma camera or single-photon emission computed
tomography (SPECT)/computed tomography (CT). The 90Y decay process has a very small
branching to the excited state of stable 90Zr, which is followed by an internal pair production
(~3.2 × 10−5 per β-decay) (50). The positrons generate a pair of 511-keV annihilation

photons that can be imaged using PET/CT. Several recent studies have suggested that 90Y

positron emission tomography (PET)/CT imaging is superior in image resolution, image
contrast, and quantitative accuracy compared to 90Y bremsstrahlung SPECT/CT (24–26).
Because liver is subject to respiratory motion, in vivo imaging of the liver is
degraded by motion blur artifact. Typically acquisition duration of 15–30 min/bed is used to
compensate the extremely low 90Y-PET signal. During the long PET acquisition, respiratory
motion causes motion blur attributable to the time-averaging of multiple breathing cycles (a
normal breathing cycle is typically 4 seconds). Extensive studies of the impact of respiratory
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motion in fludeoxyglucose (18F) (18FDG) PET have demonstrated that motion artifacts cause
blurring of the target volume margins and underestimation of PET standardized uptake
values (SUV) (41–44).
Respiratory-gated PET/CT acquisitions group the acquired data into smaller phase
or amplitude-matched bins to reduce motion blur, but at the cost of increasing noise, owing
to the lower counts in each bin (46). To simultaneously avoid this increase in noise and the
potential for data misregistration (between the PET and CT images) that results from
spatiotemporal mismatch (43, 89, 90), PET emission data can be acquired in a quiescent
respiratory phase, such as end expiration, in which the motion is relatively low. Quiescentperiod gating (QPG) was developed to allow free breathing acquisition while reducing the
motion artifact (45). In high-count studies like 18FDG PET/CT imaging, it is clinically
feasible to increase the acquisition duration (by a factor of 3 to 5 or, equivalently, by 10–15
min) to compensate for the noise penalty from gating. However, in a 90Y-PET/CT
acquisition, in which the number of positron emissions is 0.033% of that of an equivalent
18

FDG scan, increasing the acquisition duration (for example, to 60–100 min/bed) to

compensate for the noise penalty caused by respiratory binning is not practical.
Previous work on PET motion compensation in 18FDG scans has compensated for
underestimation in SUVmax or SUVmean; however, in these studies, the main imaging task was
tumor detection, not measurement of the 3-dimensional (3D) activity or dose distribution.
Post-90Y-microsphere therapy quantitative PET/CT imaging has been extensively researched
over the past several years, but studies still focus on the mean activity concentration (AC),
which is more relevant to diagnostic imaging than to post-therapy imaging (24, 66, 67, 91).
Post-90Y-microsphere therapy PET/CT imaging provides the unique opportunity to make
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voxel-level absorbed dose calculations that can subsequently be used to predict tumor control
probability and toxicity to normal tissue, which will enable the development of more
personalized and more effective treatment strategies.
Drawing from radiation oncology, 3D voxel-level dosimetry calculation is often
characterized by the cumulative dose volume histogram (DVH) (76, 77, 92, 93). It has been
suggested that the dose distribution in 90Y-microsphere therapy can readily be calculated
from the 90Y activity distribution images by assuming local energy deposition of the
electrons (35, 51). Voxel-based dosimetry methods for 90Y-microsphere therapy have been
developed recently (20, 34, 51, 94). Those methods calculate the dose distributions from the
3D AC distribution either from surrogate 99mTc-MAA SPECT/CT images or from 3D 90Y
images (bremsstrahlung SPECT/CT or PET/CT) as the input functions. One limitation of
voxel-based dosimetry is the accuracy of the inputs, which are subject to image-degrading
factors such as image noise and motion blur (40).
The local deposition method assumes proportionality between absorbed dose to the
voxel (in Gy) and activity concentration (in Bq/mL), which is the unit of voxels in PET
images; therefore we propose to present DVHs as activity concentration volume histograms
(ACVHs). The ACHV plots the threshold AC (abscissa) against the fraction of the volume
of interest (VOI) with AC greater than or equal to the threshold (ordinate). ACVH also
provides information about the conventional summary metrics, such as minimum, maximum,
and median AC. The ordinate of ACVH spans 0% to 100% and the width of the ACVH curve
around the median (50%) serves as an indicator of the non-uniformity of the 3D AC in the
VOI; greater spread indicates a higher degree of non-uniformity. We characterized the
effects of image noise and motion blur on ACVH estimates in count-limited phantom studies
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mimicking 90Y PET/CT images. We also investigated whether the motion errors in the
ACVH under very low-count conditions can be effectively compensated for using QPG.

5.2.

Methods

5.2.1.

Data acquisition
All PET/CT images were acquired using a GE Discovery 690 (General Electric

Medical Systems, Milwaukee, WI). We assessed image quality and quantification using the
National Electrical Manufacturers Association (NEMA) International Electrotechnical
Commission (IEC) body phantom (Data Spectrum Corp., Chapel Hill, NC). A small amount
of 18F was injected into the IEC phantom as a surrogate radionuclide to simulate the inherent
low count typical of 90Y PET/CT studies. We matched the total number of positrons emitted
in a 18F scan for 47 s/bed acquisition to those in a 90Y scan for 30 min/bed by equalizing the
activity × positron yield × acquisition duration. The typical 90Y scan emulated was for a
mean liver dose of 30 Gy with tumor uptake ratio of 10 (22, 24). The IEC phantom was
prepared with 18F AC in the background of 0.8 kBq/mL (equivalent to 600 kBq/mL for 90Y)
and a sphere-to-background ratio (SBR) of 9.6.
The PET data were acquired using a 1-bed position, centered at the spheres. We
only acquired CT images of a static phantom to calculate the attenuation correction. We did
not expect any significant motion errors in the attenuation map because both the spheres and
background contain water, and the thin acrylic walls of the spheres have attenuation similar
to that of water, at 511 keV.
All images were reconstructed using 3D Ordered Subset Expectation Maximization
(OSEM) iterative reconstruction with time-of-flight correction and point spread function
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modeling (GE Vue Point FX-S) using the following parameters: 2 iterations and 24 subsets,
50-cm field of view, 5.2-mm post-reconstruction axial filter, and standard z-axis filter.

5.2.1.1. Effects of total count on 3D activity quantification
To establish a high-count reference dataset, we acquired PET data of the 18F IEC
phantom for 300 s (equivalent to a 3 hour/bed 90Y scan). These data were down-sampled to
shorter durations per bed position: 47 s (equivalent to clinical 90Y total counts, i.e., 100%),
40 s (85%), 32 s (68%), 24 s (51%), 16 s (33%), and 8 s (17%). Data down-sampling for
each duration was done on 5 independent time windows to determine statistical variations in
the activity distribution quantification.
5.2.1.2. Effects of motion on 3D activity quantification
To evaluate the effects of motion on activity quantification, we acquired 4 PET
datasets with the IEC phantom: a single static reference acquisition and 3 motion-degraded
PET data with periodic motions of 1-, 2-, and 4-cm amplitudes. The phantom motion was
tracked using a real-time position management device (RPM, Varian Medical System, Inc.,
Palo Alto, CA) (95). We used an in-house motion platform (96) that uses a linear stage
(Velmex, Inc., Bloomfield, NY) to simulate regular 1D respiratory patterns, with a typical
period of 4 s and amplitudes of 1, 2, and 4 cm (Fig 22). To reduce the compounding effect

of image noise (section B.1.1), all PET data sets with motion were acquired for 300 s. These
300-s data sets had lower noise (background standard deviation [SD] of 15%) than do
clinical 90Y PET images (background SD of 40%).
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5.2.1.3. Effectiveness of QPG as compensation for 3D AC distribution in a countlimited study
We evaluated the ability of the QPG to effectively trade off motion blur and image
noise in a count-limited PET study by improving the image contrast-to-noise ratio (CNR) and
AC quantification. The 4 datasets acquired in section B.1.2 were down-sampled to 47 s to
yield the total number of counts expected in a clinical 90Y PET scan. The 3 motiondegraded datasets were retrospectively binned into 3, 4, and 5 respiratory-phase gates over
the 4-s motion period; the PET images were then reconstructed for each gate to create 4D
PET images.
The motion artifacts in the images were compensated using 2 QPG, with count
(time) fractions of 25% and 33%, i.e., a single respiratory gate was used for image
reconstruction from 4D PET that was gated with 4 and 3 respiratory bins, respectively. We
also co-registered adjacent gated images (post-reconstruction) during the quiescent period to
create QPG images with count fractions of 40% and 50%, i.e., to co-register 2 gated images
in 4D PET with 5 and 4 bins (Fig 22), respectively.
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Fig 22. The ilustration of the gating timing of quiescent period gating (QPG) motion
compensation on 1-D motion input function with period of 4 s and amplitude of 1, 2, and 4
cm. QPG images with a count fraction of 25% were created by selecting 1 gated image in
the quiescent period from a 4D PET image with 4 gates. QPG images with a count fraction
of 2 × 25% were created by co-registering 2 adjacent gated images in the quiescent period
from 4D PET with 4 gates.

5.2.2.

Data analysis
The hot spheres, which represented tumors, were segmented out using sphere VOIs

contoured from the corresponding CT images (Fig 23). The diameters of the VOIs were
matched to the sphere diameters (from the NEMA IEC phantom manual) and were verified
from the CT images of the sphere inserts. For static PET images, all VOI locations were
registered to the CT images of the spheres. For PET images with motion blur, the VOI
locations in the bed axis (along the motion direction) were manually adjusted by registering
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the VOIs and the sphere location in the PET images; the centers of all VOIs were still coplanar.
The normal liver tissue surrounding the tumor was represented by a 126-mL
cylinder containing a 1.7-cm sphere (Fig 23). The spherical VOI (diameter of 1.7 cm) was
segmented out from the cylindrical VOI to simulate uniform 90Y activity in normal tissue
around the tumor.

Fig 23. Size and placement of the volumes of interest (VOIs) from which activity
concentration distributions were quantified. The spherical and cylindrical VOIs represent,
respectively, tumors and normal tissue surrounding the 17-mm “tumor” in transaxial (A) and
coronal (B) views.

To quantify the AC distribution, we calculated the cumulative ACVH for all VOIs
(6 spheres and 1 background) for the 4 PET image acquisitions. In addition, we calculated
the ACVHs for each down-sampling and gating method.

5.2.2.1. Effects of total count on 3D activity quantification
The ACVHs of both the sphere and the background were calculated for all static
PET images with durations of 300 s (reference images), 47 s, 40 s, 32 s, 24 s, 16 s, and 8 s.
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The ACVHs for 47, 40, and 32 s images were calculated as the average ACVH from 5 downsampled scans; whereas the ACVH for 24, 16, and 8 s were calculated as the average of 10
down-sample scans. The variability of the ACVH was measured as the standard deviation of
multiple down-sampled scans of the same total duration. The ACVH for each down-sampled
image was compared graphically against those for the reference images. The ACVHs were
compared quantitatively by computing the deviation of the AC of the PET images from that
of the reference image as a function of cumulative volume.
For the spheres, we also reported the difference in mean AC (ACmean) and
differences in ACX (defined as the minimum AC that covers X% of the VOI) that are
typically used in tumor dosimetry; for example, AC90, AC80, and AC50 as a function of total
count (or duration). The relationship between the ACVH parameters AC90, AC80, AC50, and
ACmean and the count densities was evaluated using linear regression analysis; the slopes and
the corresponding p value were reported.

5.2.2.2. Effects of motion on 3D activity quantification
We visually analyzed the effects of motion in the sphere images by comparing the
motion-degraded images with the static reference images. We also compared line profiles of
the sphere images along the motion direction as a semi-quantitative analysis of the motion
blur.
The ACVHs of both the sphere and background were calculated for all high-count
static (reference) images and high-count motion-degraded PET images. The ACVH for the
motion-degraded images was compared graphically against the ACVH for the static
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reference images. The ACVH values were also compared quantitatively by computing the
errors in AC of the motion-degraded images with respect to the reference static image as a
function of cumulative volume.
In addition, for sphere images, we used linear regression analysis to evaluate the
relationship between the errors in ACmean and the relative motion (motion amplitude/sphere
diameter) for 5 sphere diameters (37, 28, 22, 17, and 13 mm). 1 The Pearson correlation
coefficient and the p value were reported.

5.2.2.3. Effectiveness of QPG to compensate for motion errors in 3D AC distribution in
count-limited PET images
We evaluated the effectiveness of motion compensation using QPG with count
fractions of 25% and 33% by quantifying the relative change (with respect to the static
reference images) in image CNR and AC with and without QPG.
The effectiveness of motion compensation in the sphere images was visually
analyzed by comparing the in-motion images with and without motion compensation to the
static reference images. The CNR of the spheres was also calculated, as (sphere ACmean –
background ACmean) / (background SD of mean), to evaluate the improvement in the image
contrast.
The ACVHs of both the sphere and the background were calculated for static
reference images and in-motion PET images with and without motion compensation. The
ACVH of the in-motion images was compared graphically against the ACVH of the static

1

The 10-mm sphere in IEC phantom was not detectable due to the very high noise, so the 13-mm sphere was
the detection limit.
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reference images. We also quantitatively compared the ACVHs by computing the errors in
AC of the in-motion images before and after motion compensation. All errors were reported
as differences from the static reference images.
For the reconstructed sphere images, we used linear regression analysis to evaluate
the relationship between ACmean and relative motion before and after motion compensation
for 5 sphere diameters at 3 different motion amplitudes. The significance of the differences in
the slopes of the linear regression curves before and after motion compensation were
evaluated using a 1-sided t-test.

5.3.

Results

5.3.1

Effects of total count on 3D activity quantification
Reducing the acquisition duration resulted in an increase in the image noise, as

shown in Fig 24A. The range of observed AC increased with lower acquisition duration, i.e.,
the measured minimum AC decreased while the maximum AC increased (Fig 24B and Fig
24C). The increase in the non-uniformity of the AC distribution was more pronounced in the
smaller spheres, i.e., the change in the ACVH spread was greater for the 17-mm sphere than
for the 37-mm sphere. Because of the lower AC in the background (SBR of 9.6), the
increase in AC distribution inhomogeneity was higher in the background region, as shown in
the images in Fig 24A and the ACVHs in Fig 24C. The observed profiles were substantially
different that the ideal ACVH, in part, due to the partial volume effect; the differences from
ideal were less pronounced in the background compared to the tumor VOI (Figures 3B and
3C).
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Fig 24. (A) Transaxial PET images of an IEC phantom acquired for the indicated durations.
The window width and level of these images were adjusted manually to show the texture of
the sphere images. (B, C) Activity concentration volume histograms (ACVH) for (B) the 17mm sphere and (C) the surrounding background region as the acquisition duration varied.
Note: the gray dashed ACVHs show ideal ACVH calculated from known activity assays.
The ACVHs in (B) and (C) were average ACVH from multiple down-sampled scans.
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AC20 to AC40 was observed to be less sensitive to duration reduction (< 10%
deviation from the low-noise reference), as shown in Fig 25A. At an acquisition duration of
32 s (68%), the ACVH errors were comparable to the errors (< 5% difference) at the 47-s
acquisition (100%), except beyond AC90. At acquisition duration of 8 s (17%), the errors
were > 10% outside the AC20 to AC40. Fig 25B shows the ACVH errors as a function of
acquisition durations for several ACX that are typically used in tumor dosimetry. The errors
and variability of ACmean were independent of a reduction in acquisition duration down to
17%. The slope of ACmean versus the acquisition duration was statistically consistent with
zero; while the slopes for other ACX were non-zero and statistically significant (p < 0.05).
The magnitude of both ACX errors and ACX variability monotonically increased away from
ACmean (at around AC30) toward both extremes, i.e., AC0 (ACmax) and AC100 (ACmin). The
variability of ACX was also affected by the object and VOI sizes; the SD for the 37-mm
sphere was smaller than it was for the 17-mm sphere. Similar trends were observed for
ACVH parameters in the background VOIs.
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Fig 25. (A) Errors in the 17-mm sphere activity concentration volume histogram (ACVH)
with respect to the ACVH calculated from reference images for multiple acquisition
durations. (B) Errors of activity concentration (AC) parameters that are typically used in
tumor dosimetry as a function of acquisition duration for the 17-mm sphere. The error bars
represent ± 1 standard deviation.

5.3.2.

Effects of respiratory motion on 3D activity quantification
Motion blurred the activity distribution of the spheres across a volume larger than

the actual sphere diameter, causing underestimation of the actual sphere AC and an increase
in the surrounding background AC, as shown in the sphere images and their line profiles in
Fig 26. The magnitude of the underestimation depended on the relative motion amplitude
with respect to the sphere diameter.

Fig 26. (A) Coronal PET images showing the motion blurring artifact from the breathing
pattern (shown in Figure 1) on 37- and 17-mm spheres. Z line profiles of 37-mm (B) and 17mm (C) spheres extracted from the PET images (location shown by the dashed blue lines in
[A]).
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The ACVHs for the spheres and the background regions under 1-, 2-, and 4-cm
motion patterns are shown in Fig 27A and Fig 27B, respectively. The average errors
(relative to the static case) in sphere ACmean were −4%, −16%, and −52% for the 37-mm
sphere under 1, 2, and 4-cm motion amplitudes, respectively; these errors increased to −6%,
−27%, and −64% for the 17-mm sphere. The maximum AC (AC0), however, was not
underestimated if the relative motion was < 1, as shown in Fig 27. The errors in the other
ACX values, AC90, AC80, and AC50, followed a similar pattern as that of ACmean; the variation
in errors for these parameters was about 10% from the ACmean.
The ACVH was relatively unchanged by 1-cm motion for the 37-mm sphere but
showed more substantial underestimation for the 1.7-cm sphere with the same 1-cm motion
(Fig 27A). The error magnitude of ACmean depended on the relative motion; the Pearson
correlation coefficient of the error in ACmean against the relative motion was 0.90 (p <<
0.001). At small relative motion values (≤ 0.5 cm), the errors in ACmean due to motion blur
were small (≤ 5%).
Fig 27B illustrates the increase of AC (about AC30 to AC10) in the region
surrounding the 17-mm sphere. The increase was higher for wider motion amplitudes.
Nevertheless, the ACVH errors in the background region that were attributable to motion
were minimal. For 4-cm motion blur, the ACVH errors were < 10% at AC10 to AC80 because
the motion blur covered only a small fraction (< 5%) of the background region VOI.
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Fig 27. Cumulative volume histograms from volumes of interest in (A) the 17-mm sphere
and (B) background regions under the static reference condition and motion with 1-, 2-, and
4-cm amplitudes.

5.3.3.

Effectiveness of QPG to compensate for motion errors in 3D AC distribution in

count-limited PET images
QPG (with various count fractions) reduced the severity of motion blur. As shown
in Fig 28A, the narrower the QPG gate width, the greater the reduction in motion blur. The
17-mm sphere images (with 4-cm motion amplitude) that were compensated using QPG with
a count fraction of 25% had less motion blur than those compensated using QPG with a count
fraction of 33%. Narrower gate widths, however, had smaller total counts, which led to an
increase in image noise and consequently an increase in image non-uniformity, as is evident
from the stretch in the ACVH of the motion-compensated images (Fig 28B, C for the 17-mm
sphere and Fig 28D, E for the surrounding background region). The increase in nonuniformity from QPG was consistent with the increase in non-uniformity from reduced
acquisition duration (Fig 28). This trade-off between motion blur reduction and increase in
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image noise is apparent from the CNRs of the 17-mm sphere images under various
conditions (Fig 28A).

Fig 28. (A) Images of the 17-mm sphere under the static condition and with the 4-cm motion
amplitude without and with quiescent period gating (QPG) with various count fractions. The
contrast-to-noise ratio (CNR) of the 17-mm sphere is shown. (B, D) Activity concentration
volume histogram of (B) the 17-mm sphere and (D) the surrounding background region. (C,
E) Error in activity concentration coverage with respect to the static condition as a function
of cumulative volume for the 17-mm sphere (C) and the background region (E).
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The average errors in AC10 to AC80 were reduced from −25% and −55% to −10%
and −15% for sphere images degraded by motion with amplitudes of 2 cm and 4 cm,
respectively. Similarly, the underestimation of the ACmean of the 1.7-cm sphere was reduced
from ~30% and ~50%, respectively, to ~10% for both 2-cm and 4-cm motion. Fig 29

shows the errors in ACmean before and after QPG (2 × 20%) as a function of relative motion
for all sphere images (37–13 mm) under the 3 motion patterns evaluated (amplitudes of 1, 2,
and 4 cm). The t-test indicated that the difference in the slopes before and after QPG was
significant (p = 0.029). With QPG, the errors in ACmean (with respect to the low-noise
image) were reduced to about 10%, regardless of the relative motion. The QPG reduced the
motion blur errors at all AC levels. AC40 to AC60, however, suffered from errors attributable
to increased noise.

Fig 29. Errors in mean activity concentration (ACmean) as a function of relative motion
(motion amplitude/sphere diameter) for sphere images (37–13 mm) under 3 motion patterns
(amplitude of 1, 2, and 4 cm) with and without motion compensation.
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ACVH for the background region has reduced counts fractions following QPG, the
errors in the ACVH after QPG were dominated by the reduction in counts. The motion
errors in all cases were < 10% for AC10 to AC80.

5.4.

Discussion

5.4.1. Bias and variability in AC quantification
At the typical level of total count realized in clinical settings for 90Y PET with 30
min/bed, the overall errors from both bias and variability in the static case (with no
respiratory motion) for AC90 and AC80 were within 10% (Fig 25). In realistic scenarios with
respiratory motion, when QPG motion compensation was used, the total count decreased to
about 30%, and the expected overall error in AC90 and AC80 was > 50%. In this case, AC50
and ACmean were less sensitive to the total count reduction. Dose-response studies of both
brachytherapy (70) and other radiopharmaceutical therapies, such as 131I (29) and 177Lu (97),
have suggested a strong correlation between AC90 (or AC80) and tumor response metrics.
Furthermore, these studies also demonstrated that ACmean (or AC50) was not significantly
correlated with tumor response. AC60–AC80, which may be more relevant to tumor
dosimetry, had errors of about −15% at an acquisition duration of 16 s (33%) or 10 min/bed
for 90Y PET.
It is noteworthy that in this study, the 100% sphere total count represents a tumor
with an AC of 6 MBq/mL acquired for 30 min/bed. (24)(2013) found that tumor AC ranged
from 2000 to 13000 kBq/mL. Assuming a local deposition method (35, 51) to convert the
AC map to the dose map, an AC of 6 MBq/mL would result in a tumor dose of 290 Gy,
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which is in agreement with the finding from (22) (2013). Depending on the actual tumor AC
and the acquisition duration, the overall errors may vary.

5.4.2.

Effectiveness of QPG to compensate for motion errors in 3D AC distribution in

count-limited PET images
QPG shows potential for reducing errors in ACVH in quantitative 90Y PET/CT
studies that suffer from motion blur. Qualitatively, a single-gate QPG, e.g., QPG 25% or
QPG 33%, did not show improvement in sphere detectability (measured using CNR).
Although the sphere image showed a reduction in motion blur, it also displayed increased
noise (Fig 30A). Quantitatively, sphere images with QPG motion compensation improved
ACVH over uncorrected ACVH, i.e., the compensated ACVH was closer to the static
ACVH.
As shown in Fig 30 the total counts limit the effectiveness of QPG. After QPG with
a count fraction of 33%, the compensated ACVH of the 17-mm sphere under both 2-cm and
4-cm motion agreed with that of the ACVH of static images with a 33% total count. A noiserelated error of 15% in AC60–AC80 for the 17-mm sphere image acquired for 16 s was also
achievable after QPG with similar image noise (Fig 30B). For tumors with relative motion ≥
0.5, QPG with various count fractions can be applied to reduce the errors in ACVH.
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Fig 30. (A) Activity concentration volume histogram (ACVH) of the 17-mm sphere under
static condition, with motion without correction, and with quiescent period gating (QPG)
motion compensation (33% count fraction). (B) Differences in the ACVH curves in (A) with
respect to static ACVH (100% total count) as a function of cumulative volume. Note: figure
legend in (A) and (B) are the same.

Registration of 2 adjacent gated images during the quiescent period increases the
total count and reduces noise. However, gated images acquired during the quiescent period
may not be completely motionless, depending on the breathing motion pattern. The images
may also have different residual motion, as shown in Fig 28. For instance, QPG 25% will
have less motion blur than QPG 2 × 25%. Consequently, the sphere CNR of QPG 2 × 25% is
comparable to that of QPG 25%, as illustrated in Fig 28A.
Optimizing the trade-off between the motion blur reduction and the increased noise
is beyond the scope of this study, as such optimizations strongly depend on the specific
imaging conditions and imaging tasks; therefore, optimization needs to be performed on a
case-by-case basis. As an example, for the 17-mm sphere, QPG 25% reduced the errors in
ACVH better than QPG 2 × 25% did for 2-cm motion. However, for 4-cm motion, QPG 2 ×
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25% yielded lower ACVH errors than did QPG 25%, although the sphere CNR was
comparable (Fig 28A). Another practical consideration is that in clinical settings, deformable
image registration may be required, and misregistration errors will produce errors in AC
quantification (45, 89, 98). In addition, the errors in the ACVH of the background region are
dominated by the errors from noise; the errors due to motion were < 10%. Our results
suggest, therefore, that the QPG method is not effective for motion compensation in the
background region (Fig 28D and Fig 28E).
Our data show that QPG need not be applied to tumors with relative motion < 0.5,
i.e., with motion amplitude half of the tumor size. Applying QPG in such cases results in an
error in ACmean of about 10% (Fig 29). In these cases, the errors in activity quantification
introduced by motion are of the same order as, if not smaller than, the errors introduced by
the reduced total count. In a real clinical case, respiratory motion is the largest in the
superior-inferior direction, with a typical amplitude of about 2 cm. By comparison,
hepatocellular carcinoma tumors are typically > 2 cm, while metastatic liver tumors from
colorectal cancer are typically < 1 cm.

5.4.3.

Study limitations
Although the specific count-limited study of interest is 90Y PET images, we used

low amount of 18F after careful matching of the total positron emissions to evaluate the
noise trade-off of using QPG to compensate for respiratory motion. Furthermore, we do not
expect substantial differences in intrinsic image resolution because the maximum positron
energies of 18F and 90Y are very close (0.635 MeV vs. 0.63 MeV, respectively) (25, 99).
The overall image quality, however, may be somewhat different because random
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coincidence event from bremsstrahlung photon and prompt gamma detection may not be
modeled properly in 90Y-PET image reconstruction, which is optimized for 18F imaging (27,
100).
Second, we used an IEC phantom, which has uniform activity distribution in both
spheres and background, to represent tumor tissue and normal liver tissue. In reality, the
geometry and activity distributions in tumors and normal liver background are not
necessarily homogeneous. Further studies using anthropomorphic phantoms and/or clinical
90

Y PET/CT studies are needed to evaluate the effectiveness of QPG for motion

compensation and to determine the optimal count fraction for use in clinical studies. Our
study also used a single SBR of 10, which is typical for the 90Y-microsphere tumor-tobackground ratio reported by some PET/CT clinical studies (24). We expect that changes in
SBR will change the magnitude of the observed phenomena, but will not change the general
trend.
Third, we only considered 1D periodic motions with a period of 4 s and fixed
amplitudes of 1, 2, and 4 cm because of tracking device hardware limitations. Irregular
motions may introduce additional uncertainty in AC quantification (42, 43, 90). We expect
that different periods, however, will only change the relative motion range in the gated
images.
Fourth, we did not correct for partial volume effects beyond using the built-in point
spread function correction in GE VuePoint. However, we excluded partial volume effects as
a potential source of error by using the reference static images.
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Finally, we only considered the QPG single-gate and double-gate summation
regimes. Motion correction techniques that avoid increasing acquisition duration are under
development, including pre-reconstruction corrections that use data-driven approaches and
motion corrections for use during image reconstruction (101). These methods, however, are
not yet commercially available for clinical use. It would be valuable to evaluate whether
these data-driven correction methods will benefit count-starved 90Y PET studies as much as
they do high-count 18F studies.

5.5.

Conclusion
Caution needs to be exercised when using ACVH parameters such as AC90 and

AC80 to calculate absorbed dose because the ACVH is susceptible to image degradation from
both image noise and respiratory motion. When using gating-based motion compensation,
e.g., the QPG method studied here, with 33% total count in the gated image, the overall error
(bias and variability) in AC90 and AC80 can be over 60%. The ACmean seems to be less
sensitive to image noise, but its correlation with clinical response to radiation therapy has not
yet been established.
The average error in sphere ACVH (from AC10 to AC80) with relative motion
(motion amplitude/sphere diameter) less than about 0.5 was found to be < 10%. QPG can be
used to reduce motion blur artifacts and reduce the errors in sphere ACVH down to 10–15%
(limited by the total count acquired), but at the expense of increased image noise. QPG was
found to be ineffective for the quantification of background AC distribution.
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Chapter 6: Discussion

6.1.

Summary
The hypothesis of this dissertation work was that optimization of Y90 emission

data reconstruction can maintain the overall errors (systematic and random) in volumetric
dose quantification to < 20% in clinically relevant imaging conditions
Hence the main objectives were 1) to optimize the emission data reconstruction, and
2) to characterize both systematic and random errors in volumetric dose quantification from
the optimized emission images.
We tested the hypothesis on both SPECT in specific aim 1 (Chapter 2) and on PET
in specific aim 2–4 (Chapter 3–5) images.
We developed a practical protocol for improving image quality and quantification
of bremsstrahlung SPECT/CT (bSPECT) imaging in specific aim 1. We found severe partial
volume effect (PVE), where the systematic bias in mean dose of 37-mm sphere > 50%, due
to electron staggering in bremsstrahlung photon production and sub-optimal collimator
design to image bremsstrahlung photons. Because of high systematic errors due to PVE,
volumetric dosimetry using bSPECT is very challenging; Monte-Carlo simulation based
image reconstruction and/or a bSPECT-optimized hardware design are needed to improve the
image resolution. Nevertheless, we have shown that with proposed CT attenuation correction
and background compensation, we can accurately quantify the total 90Y activity delivered to
the patient with errors < 5%.
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In specific aim 2, we optimized PET image reconstruction parameters (equivalent
iterations and filtration full width at half maximum) for volumetric 90Y dosimetry by
minimizing the root mean square errors in the image-based dose volume histogram estimates
(DVH’). In the process, we also minimized the systematic error in the quantitative
image/dose map due to noise realization in image noise. For ordered subset expectation
maximization with time of flight and point spread function correction algorithm in General
Electric PET/CT system, the optimal reconstruction parameters were 36 equivalent iterations
with 5.2-mm post-reconstruction filtration. Using these parameters, spheres under various
clinically relevant imaging condition (diameter > 17 mm, sphere-to-background ratio > 4,
sphere dose > 40 Gy, acquisition duration > 10 min) were found to have minimum errors in
DVH’.
The systematic and random errors in DVH’ were characterized in specific aim 3 and
4. In specific aim 3, we showed that the (additional) systematic errors due to image noise
(manifestation of low signal) were < 10% for clinically relevant imaging condition tested.
The systematic errors in DVH’ were still dominated by the PVE (> 30%), even at countlimited study 90Y PET. The random errors (measurement repeatability), however, were
governed solely by the low signal. Random errors of < 10% can be expected in DVH’ of
sphere images under relevant clinically imaging condition, provided that the acquisition
duration of 30 min. Under shorter acquisition duration (e.g. 10 min) or if gating-based
motion compensation method (e.g. quiescent period gating) is applied, then sphere with
diameter ~17 mm will have random errors of > 15%; even though larger sphere (e.g. 37-mm

sphere) will still have random errors < 10% at sphere dose> 80 Gy. To keep random errors <
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10–15%, longer acquisition duration is required; in clinical practice, the maximum practical
limitation will likely be 30 min/bed for 2 bed positions (60 min total duration).
In specific aim 4, we characterized a specific source of systematic errors, namely
motion blur. We found that without any motion compensation, spheres with relative motion
range (motion amplitude/sphere diameter) > 0.5, errors in DVH’ > 20%. Using gating-based
motion compensation (QPE method), we traded off the systematic errors due to motion with
a combination of systematic and random errors due to low signal (from gated data).
Although we have shown that the systematic errors due to motion blur can be reduced to
<10%—which is consistent with systematic errors due to increased image noise found in
specific aim 3—the random errors increase due to data gating with magnitude depending on
the sphere diameter and acquisition duration such that spheres with motion range < 0.5 will
not benefit from QPG and spheres with motion range > 1 will likely benefit from QPG. The
total errors reduction using QPG will vary on case-by-case basis; hence it would be
recommended that motion tracking is performed on all 90Y PET scan such that the QPG
method can be applied when deemed necessary.
Our finding from development of practical bSPECT did not support our central
hypothesis since bSPECT images suffer from very high PVE even at 37-mm sphere.
Volumetric dosimetry using bSPECT will suffer errors >> 50%. Data from specific aim 2–4,
on using optimized PET images to estimate DVH’, support the central hypothesis under
certain imaging condition: effective tumor diameter > 37 mm, average tumor dose > 60 Gy,
acquisition duration > 10 min. Under this imaging condition, the errors in dose that covers
80% of the volume of interest are < 30%. The errors in Dmean and D70 are < 20%.
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6.2.

Listed contributions of this dissertation

6.2.1. Physics contributions
1) Characterization of the impact of low count (a unique challenge in 90Y PET) on systematic
and random errors in volumetric dosimetry.
2) Characterization of the impact of motion blur and the effectiveness of QPG in trading-off
motion blur and reduced count in an already count-limited 90Y PET study.
3) Establishing the expected errors (systematic and random) in image-based dose volume
histogram.
6.2.2. Clinical contributions
1) Development of practical bSPECT image reconstruction for improved image quality and
limited quantification.
2) Development of practical PET/CT image reconstruction for volumetric 90Y dosimetry.
3) Establishing the robustness of the dosimetry metric (DVH’ summary metrics) which is
important in developing dose-response model.
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6.3.

Future directions

6.3.1.

Continuation to minimize errors in volumetric 90Y dose quantification

6.3.1.1. Robustness of volumetric 90Y dosimetry in heterogeneous distribution
One of the major limitations in our present work is that we represent liver tumor
using spheres with uniformly distributed 90Y dose. In reality, the 90Y dose distribution in the
tumor is heterogeneous, which increases the complexity of correcting DVH’ for PVE, dosedependent error, etc. In the future, we plan to characterize the errors in DVH’ for (pseudo)
heterogeneous distribution, for example by using a cluster of smaller spheres.

6.3.1.2. Partial volume correction
We have shown that despite having very limited counts, the errors in volumetric 90Y
dosimetry calculated from both bSPECT and PET images are still dominated by PVE;
therefore effort to improve volumetric 90Y dosimetry should first focus on partial volume
correction.
In our present work, we used the point-spread-function (PSF) correction available
on GE OSEM algorithm (Vue Point). While the errors in mean dose (Dmean) are reasonable
(< 10% for 37-mm sphere), the errors toward minimum dose (e.g. D80) are > 30% for 37-mm
sphere with minimal systematic errors due to image noise. Traditionally for quantitative
diagnostic imaging, where Dmean is the quantity of interest, partial volume correction can be
carried empirically using look-up correction factors for different object sizes based on
phantom studies. In post-therapy 90Y imaging, however, the summary DVH’ metric of
interest has not yet been determine and hence we remain interested in a wide range of DVH’
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metrics (e.g. D20–D80). We hypothesize that the empirical partial volume correction method
to correct for Dmean, can be extended to correct for DVH’ by using correction functions,
which is subject to our future study.
More complicated partial-volume-correction methods that involve the use of prior
image information (e.g. CT or MRI images) can be very challenging to be applied for 90Y
microsphere studies; the mechanistic nature of microsphere distribution means that the
distribution of microsphere is not confined to the tumors only. The microsphere distribution
needs to be match with the vasculature which may not be resolveable in the CT or MR
images, or otherwise may not be feasible to co-register the anatomical images with the PET
or SPECT images.

6.3.1.3. Breathing motion correction
90

Y PET data needs to be acquired for a long duration, 30 min/bed at least because

the signal in 90Y PET comes from a very low positron yield of 32 ppm. The number of
counts in 90Y PET data is a scarce commodity. In QPG method, however, we used only 33%
of the counts collected, which leads to increase in both systematic and random errors in
volumetric 90Y dosimetry.
Ideally in 90Y-PET/CT study, we want to reconstruct the PET images using all the
acquired data by combining the gated data during image reconstruction(89, 102) or by
spatially registering all (post reconstruction) gated images(103, 104) together. The latter may
not be feasible in 90Y PET because gated PET images suffers from errors due to higher noise
penalty(89), while gated CT are subject to temporal mismatch (43, 90) between several
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seconds CT data with up to 60 min PET data. Combining the gated data during image
reconstruction using motion pattern from real-time position management device or datadriven method may allow more effective error reduction in DVH’ compared to QPG method.

6.3.1.3. Development of dose-response model to predict treatment outcome
The long term goal of this project is to be able to predict the efficacy of 90Y
microsphere therapy based on the post-therapy images. To achieve this goal, we need to
develop a dose-response model. In this dissertation work, we characterized the robustness of
potential dose metrics (e.g. D70 or Dmean that have been used by other studies) that may have
(strong) correlation with tumor response. Evaluation of which dose metrics have strong
correlation with tumor response cannot be done with our phantom study, since development
of dose-response model, obviously, need the tumor response data, i.e., clinical data, which
are absent in this dissertation work. In the future, we would like to develop the doseresponse model by correlating dose metrics with patient outcome.
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Appendix

A1.

Evaluation of Step-and-Shoot and Continuous-Bed-Motion modes of acquisition

for limited-view organ scans

A.1.1.

Introduction
The continuous-bed-motion (CBM) mode was originally developed to improve

axial image uniformity in whole body imaging in 2D step-and shoot (SS) acquisition
mode(105), where there were sensitivity variations in the axial direction due to gaps between
detector blocks(106). The axial uniformity, however, is no longer a problem in modern
PET/CT scanners utilizing 3D SS acquisition mode, where the axial uniformity in 3D
acquisition can be improved by overlapping the end slices of adjacent bed positions and
adding the overlapped data(107). Theoretically, CBM mode may also allow oversampling in
the z-axis direction and produce super-resolution images(108); however, this super-resolution
effect is not realized in clinical practice due to high level of noise(106).
The true clinical benefit of CBM is the ability to tailor fit the PET/CT scan length
and local scan duration based on the imaging task. In traditionally SS mode, the PET scan
length increases in steps of the PET z-axis field of view (aFOV) depending on the amount of
detector overlap between bed positions. Hence, the ability to tailor fit the PET/CT scan
length allows modest CT dose saving and facilitates trading off the scan length with the total
scan duration. In multi-bed SS acquisitions, the PET acquisition duration per bed is also
fixed; whereas in CBM mode, the local acquisition duration can be modulated along the zaxis adjusted by varying the bed speed; hence allowing acquisition of higher counts in
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regions of greater interest. In addition, clinical practice has also suggested that patients find
CBM more comfortable compared to SS acquisition(109).
Recently, the CBM acquisition mode has been made commercially available in
Siemens Biograph mCT Flow (Siemens Medical Solutions USA, Knoxville, TN). The CBM
acquisition mode is intended for whole body PET/CT imaging with long scan length
(multiple aFOVs). The benefits of CBM mode in clinical whole body imaging have been
studied(106, 110). The benefits of CBM acquisition mode in short scan length studies,
however, have not been investigated. The objective of this work is to evaluate the potential
differences in the counting efficiency profiles along the z-axis between CBM and SS modes
of acquisition for limited-view organ studies, such as 90Y PET/CT liver scan, where the scan
length is short (≤ 2 aFOV) and the scan duration is long(28, 111) (≤ 30 𝑚𝑖𝑛/𝑏𝑒𝑑). We also
discuss the implication of these differences on the image quality and quantification of 90YPET/CT liver scan.

A.1.2.

Methods

A.1.2.1. Analytical comparison of counting efficiency in CBM and SS modes
A.1.2.1.1.Counting efficiency profiles in 3D SS acquisition mode
The sensitivity (count rate per unit activity) profile of PET acquisition is
proportional to the volume of response (VOR) accepted for a given geometry(112). In 3D SS
acquisition mode, the VOR at any given axial position along the PET bed is proportional to
its distance from the edge of the aFOV, i.e., the VOR is the largest at the center and the
smallest at the edges of the aFOV (Fig 31A). The 3D SS acquisition therefore has a
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triangular sensitivity profile for scan length of 1 aFOV (Fig 31B). For multi-aFOV SS
acquisition, the overall sensitivity profiles can be calculated by adding the count profiles of
each individual aFOV acquisitions accounting for the amount of bed overlap (Fig 31C). In
reality, the axial sensitivity profile is not exactly triangular but has a saw-tooth shape with a
plateau depending on the axial compression that is used on the scanner , the maximum
acceptance angle, and the number of detectors used. An ideal simplification of sensitivity
profile is used to conceptually illustrate sensitivity/bed overlap in 3D SS modes.

Fig 31. (A) Volume of response (VOR) in 3D step-and-shoot (SS) acquisition at two
locations: a and b. The VOR varies linearly as a function of distance along the axial (z-axis)
field of view (aFOV). (B) For a single aFOV, the VOR and the sensitivity as a function of
position has a triangular profile. (C) For two-aFOV SS acquisition, the VOR profile as a
function of position is simply a summation of the individual aFOV profiles at each bed
position taking into account the amount of bed-overlap; 43% aFOV overlap in Siemens mCT
is illustrated.
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The number of counts in an image slice is proportional to the integral of its VOR
over time. For a uniformly distributed activity along the bed motion direction (z axis), the zaxis count profile 𝐶(𝑧) can be calculated as
𝑡𝑑𝑢𝑟

𝐶(𝑧) ∝ � 𝑉𝑂𝑅(𝑧)𝑑𝑡 = 𝑉𝑂𝑅(𝑧) × 𝑡𝑑𝑢𝑟 ,
0

(1)

where 𝑉𝑂𝑅(𝑧) is the volume of response at slice 𝑧 and 𝑡𝑑𝑢𝑟 is the acquisition

duration. In SS mode, the VOR varies only as a function of location inside the aFOV; hence
the count profile is proportional to the VOR.

A.1.2.1.2.Counting efficiency profiles in CBM mode
In CBM mode, the object is moving along the z-axis; hence during the acquisition,
the VOR for slice location z changes over time. The variation of the VOR at location z as a
function of time, 𝐶𝑧 (𝑡), is illustrated in Fig 32. For Siemens mCT scanner, the CBM mode is
acquired with 50% overscan, i.e., the scan prescription begins and ends at the center of the

detector aFOV(106). In this configuration, the count profile for a uniform cylindrical source
consists of 1/2-aFOV-long ramp up and down regions at the beginning and end with a flat
constant profile in between (Fig 32C). Following equation (1), the count profile for CBM
can be expressed as:
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, 𝑓𝑜𝑟 𝐿 + 𝑑 ≤ 𝑧 ≤ 2𝐿 + 𝑑,

where 𝑧 is the image slice position along z-axis, 𝐿 is half of the FOV length, 𝑑 is

the length of the uniform region, 𝑣 is the bed speed, and 𝑧 ′ = −(𝑧 − 2𝐿 − 𝑑). Note that 𝑑 is
equal to the total scan length minus 2𝐿. In reality, the actual efficiency profile depends on a
large number of hardware and software parameters that include the detector segments used
and the scan extend outside the aFOV. We have once again simplified the theoretical
derivation of the axial efficiency to conceptually illustrate the sensitivity profile in CBM
mode.
The PET and the CT acquisition have a matching scan length prescription, which
does not account for the 50% overscan in PET acquisition. Due to the missing CT-based
attenuation correction factors outside the PET/CT scan prescription, the coincidence counts
acquired in the VOR outside the scan prescription cannot be used in the quantitative PET
image reconstruction(106). As illustrated in Fig 32, the volume of response and, therefore,
the count profile at the axial extends of prescribed scan regions are limited by the attenuation
correction unavailability rather than limited by the acquisition geometry. Similar to the ideal
CBM case, following equation (1), the count profile for observed CBM mode can be
expressed as:
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Note that contrary to the ideal CBM case, in practice 𝐶(0) = 0.

Fig 32. (A) The variation of the volume of response (VOR) at location 𝒛 = 𝟎. 𝟒𝑳 (black dot)
at time t is illustrated by the empty and shaded triangles for ideal and practical cases,

respectively. Note that the continuous-bed-motion (CBM) acquisition starts with the edge of
the prescribed scan region located at the center of the axial field of view. (B) Graph of the
VOR and (C) net counts at location 𝒛 as function of time in the ideal CBM (solid blue) and
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practical CBM (red dash) modes. The variation in VOR at time points illustrated (A) are
indicated in (B). As expected the counts are lower in the practical CBM at the ramping up
and down regions. The profiles are derived for a CBM acquisition with 50% overscan.

A.1.2.1.3.Analytic comparison of counting efficiencies in SS and CBM modes
We compared the count efficiencies of three different modes of PET data
acquisition: 3D SS acquisition for 1 aFOV, 2 aFOVs, and CBM acquisition for the same
acquisition duration. For 2-aFOV scan, the acquisition duration for each bed position was
half of the acquisition duration in 1-aFOV scan to maintain the same total duration. The scan
lengths for 1-aFOV, 2-aFOV, and CBM were 22, 35, and 24 cm, respectively. The scan
length of 24 cm was chosen for CBM to provide a scan length similar to 1-aFOV while
maintaining scan duration of 40 min at the slowest bed speed of 0.1 mm/s.

A.1.2.2. Experimental verification of counting efficiencies in SS and CBM modes
All PET/CT images were acquired using Siemens Biograph mCT Flow featuring
the CBM acquisition mode (Flow Motion). The scanner has a bore diameter of 78 𝑐𝑚 and an
axial field of view (aFOV) of 22-𝑐𝑚 (4-ring detector configuration). The system is also
time-of-flight (TOF) capable with nominal timing resolution of 0.555 𝑛𝑠.

A 2-mCi 68Ge daily QC phantom with length of 27 cm and diameter of 20 cm was

scanned using 3 PET acquisition modes described previously: 1 and 2-aFOV SS, and CBM
modes to derive the count density profiles of each mode. The acquisition parameters were
the same as those used for analytical comparison (Material and Method section 1c). All
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PET/CT images were reconstructed using TOF information with CT attenuation correction,
PSF modeling, scatter correction, and OSEM iterative reconstruction (TrueX, Siemens
Medical Solutions) with subset and iteration of 2 × 21.
For all transaxial slices, the means and standard deviations of the reconstructed
activity concentration were extracted from a 40-cm2 ROI placed at the center of the phantom
images. Based on our observation, the PET image noise follows a Poisson-like distribution,
i.e., 𝑖𝑚𝑎𝑔𝑒 𝑛𝑜𝑖𝑠𝑒 ∝ 𝑐𝑜𝑢𝑛𝑡𝑠 −0.51; therefore the relative count density profiles were

computed from the relative noise measurements of the ROIs as:

𝐶∝

1
𝑚𝑒𝑎𝑛 2
=
�
� .
2
𝑠𝑡𝑑𝑒𝑣
𝜎𝑟𝑒𝑙

(4)

The relative count profiles along z axis were calculated for all 3 PET acquisition
modes. These relative count profiles were then compared to the analytically derived count
profiles (Material and Method section 1b) for validation.

A.1.3.

Results

A.1.3.1. Comparison of the sensitivity profiles in CBM and SS modes
The theoretically derived count density profiles are shown together with the
experimentally computed count profiles for 1- and 2-aFOV SS, and CBM modes in Fig 33.
The measured profiles for 1-aFOV and CBM with axial scan lengths of 22 cm and 24 cm,
respectively, are in good agreement with the theoretically derived profiles. However, the
measured profile for 2-aFOV with axial scan length of 35 cm is not fully characterized in the
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axial direction because the phantom used for the measurements is shorter in length (only ~27
cm). Nonetheless, agreement between measured and theoretical profiles for SS 2-aFOV scans
can be fully appreciated in the positive positions where the phantom extends fully. The
measured profiles are noisy while the analytically profiles were derived under idealized
assumptions, yet there is reasonably good agreement between them.
The measured profile from CBM acquisition has been demonstrated to be less
efficient compared to the ideal CBM case, as explained in Materials and Methods section 1b,
due to unusable data due to missing attenuation correction factor in the overscan region. For
fixed scan durations, the overall counting efficiency of CBM mode is lower compared to
those of 1- and 2-aFOV SS acquisition modes in terms of total PET signal (area under the
curves). CBM mode only acquired ~60% of the total counts acquired in the SS acquisition

modes for the same acquisition duration. In addition, for the same acquisition duration, the
ratio of the maximum counts in the CBM to 1-aFOV SS modes is proportional to 𝑎𝐹𝑂𝑉/

(2 × 𝑠𝑐𝑎𝑛 𝑙𝑒𝑛𝑔𝑡ℎ𝐶𝐵𝑀 ), i.e., the maximum-count images in the CBM is ≤ 50% of those for

1-aFOV SS mode, and ≤ 100% of those for 2-aFOV SS mode.
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Fig 33. (A) Comparison of the analytically derived counting efficiencies for a uniform line
cylindrical source acquired using step-and shoot (SS) acquisition mode (scan lengths of 1 and
2 aFOVs) and continuous bed motion (CBM) mode. All profiles are aligned at the central
slices to compare the trade-off between counts and scan length. The ideal CBM profile (red
dash) shows the counting efficiency for a geometry-limited CBM mode, while observed
CBM profile (solid red line) shows the counting efficiency realized in the CBM mode with
missing attenuation correction in the overscan region. (B) The profiles from analytical
derivation (dash line) showing good agreement with the experimentally derived count
profiles (solid line) for 1- and 2-aFOV SS, and CBM acquisition modes. The counting
efficiency of CBM mode is less efficient compared to the SS mode. The measured profiles
for 1-aFOV and CBM with axial scan lengths of 22 cm and 24 cm, respectively, are in good
agreement with the theoretically derived profiles. However, the measured profile for 2-aFOV
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with axial scan length of 35 cm is not fully characterized in the axial direction because the
phantom used for the measurements is shorter in length (only ~27 cm).
For a short scan length of 1 aFOV, i.e., ~22 𝑐𝑚, a plateau of lower relative noise

(based on the relative count density profiles) with 1-aFOV SS mode was realized for a region
of ~14 𝑐𝑚 around the center of the axial FOV. The extent of the lower noise plateau region
decreased to ~10 𝑐𝑚 for 2-aFOV SS and CBM modes. The 2-aFOV SS mode, however,

does provide 11 cm additional axial scan coverage than CBM mode, i.e., 35 cm compared to
24 cm, for the same acquisition time.

A.1.4.

Discussion

A.1.4.1. Effects of acquisition modes on image quality and quantitation
Both SS and CBM PET acquisition modes allow for trade-off between the counts
per unit (axial) distance and scan length for fixed acquisition duration. With SS mode the
increments in scan length are in terms on a fixed fraction of PET aFOV depending on the
prescribed bed-overlap; with CBM, however, the scan length can be increased in increments
of prescribed table speed allowed. For the same acquisition duration, the maximum count
efficiency (at the central images) for CBM mode is less than or equal to half of that for 1aFOV SS acquisition mode and less than or equal to the maximum count efficiency for 2aFOV SS acquisition mode. For the same scan length and scan duration, CBM mode only
collected ~60% coincidence counts that are collected in the 1-aFOV SS mode. For the same

acquisition duration, the maximum count efficiency of a 2-aFOV SS acquisition relative to a
1-aFOV SS mode depends on the amount of bed overlap; it is half for 50% bed-overlap.
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A.1.4.2. CBM versus SS modes for organ scan
The primary advantages of the CBM mode compared to the SS mode are that the
CBM mode offers uniform axial sensitivity profile and it facilitates effective trading between
scan length and scan duration. These advantages, however, are not realized in scans of
limited axial coverage such as scans of liver or other organs. For organ studies with scan
lengths less than ~30 𝑐𝑚, tailor fitting the scan length becomes less practical. As discussed
in detail in the material and method section 1, the CBM count density is not uniform for the
first and the last halves of the aFOV. For a scan length ≤ 2 aFOV, these non-uniform
regions comprise ≥ 50% of the total scan length.

The usefulness of CBM mode is even more restricted in studies with short scan

length and long scan duration such as 90Y liver PET/CT (10 − 30 𝑚𝑖𝑛/𝑏𝑒𝑑). The slowest

speed setting in CBM is 0.1 𝑚𝑚/𝑠 and the speed has the finest increment of 0.1 𝑚𝑚/𝑠. For
a typical liver length of 24 𝑐𝑚, the scan duration can be set to a maximum of 40 𝑚𝑖𝑛. Since

the next available speed setting is 0.2 𝑚𝑚/𝑠, the next available duration to cover the 24-cm

liver scan is 20 𝑚𝑖𝑛. Due to its finite bed speed increments, CBM mode losses its ability to
effectively trade scan lengths and durations for exams requiring long scan durations such as
90

Y PET/CT. For a short scan with long duration, SS mode gives greater flexibility in

scanning duration with net higher counts detected for 1-aFOV scan length, and net longer
scan length coverage with at least comparable net counts for 2-aFOV scan length.
For a count-starved study like 90Y PET/CT, the counting efficiency is of importance
because the image quality and quantification are strongly dependent on the number of
coincidence count detected during the acquisition. Since SS acquisition has higher counting
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efficiency compared to CBM mode, SS acquisition is more suitable for organ scan with
limited scan length and long scan duration like 90Y liver PET/CT.

A.1.4.3. Limitations
In this work, we presented simplistic models to characterize the counting
efficiencies across the aFOV both in the SS and CBM modes. Even though these idealized
models do not incorporate details(106) about data acquisition, splitting, correction and image
reconstruction, they were still effective to demonstrate the difference in the counting
efficiencies between the SS and CBM modes.
It is important to note that the lack of attenuation information outside the CBM
aFOV may be overcome by more advanced reconstruction algorithms (e.g., data driven) or
altering the CBM scan protocol (e.g., operating CBM at high bed speeds at the two end of
FOV). Use of attenuation corrected PET signal from outside the CBM scan prescription will
help push CBM sensitivity profile similar to that of 2-aFOV SS in central region (as shown in
Figure 3A).
The primary objective of this study was to optimize the acquisition protocol for
post-therapy microsphere 90Y-PET/CT studies; we, however, used 68Ge phantom as a
surrogate radionuclide.

68

Ge and 90Y may have differences in the absolute sensitivity, scatter

properties, singles, random coincidence, and resolution; nevertheless, the relative counting
efficiency in different acquisition modes should be similar. Using 68Ge instead of 90Y
allowed us to acquire higher counts in shorter duration with lower radioactivity.
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A.1.4.4. Conclusion
The benefits of CBM mode is severely challenged in studies with short scan length
(≤ 30 𝑐𝑚), due to non-uniform count density in the first and the last halves of the aFOV, and

long scan duration (20 𝑚𝑖𝑛/𝑎𝐹𝑂𝑉), due to limitation in the bed speed increment of 0.1 𝑚𝑚/
𝑠. The SS acquisition mode is preferable to CBM mode for count-starved 90Y-PET/CT livers
scans due to having higher counting efficiency, which will lead to better image quality and
quantification precision.
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